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Abstract
Copper-Catalyzed Regioselective Boracarboxylation of Vinyl Arenes:
Catalytic Efficiency and Synthetic Utility
Trina Perrone

Hetero(element) carboxylation is an appealing transformation that involves the installation of CO2
and another hetero(element) in one step. This transition metal-catalyzed one-pot synthesis
provides a route to achieve highly functionalized carboxylic acid products with an abundant and
cheap C1 feedstock. This difunctionalization also avoids the use of reactive metal hydride species,
which is a prominent limitation of hydrocarboxylation chemistry. A copper-catalyzed
regioselective boracarboxylation of vinyl arenes has been developed to access pharmaceutically
relevant β-boryl-α-aryl propionic acid products. One drawback of this reaction is the necessity for
high catalyst loading to achieve catalytic turnover. To circumvent this issue, the reduction of
catalyst loading by addition of a secondary phosphine ligand was examined to access previously
reported substrates and an expanded scope for this transformation. Trends in reactivity and
preliminary experiments to determine the role of exogenous phosphine in the catalytic system will
be described. The synthetic utility of the boracarboxylated products was investigated through a
contemporary carbon-boron bond transformation to afford fluorinated products. The reactivity
and scope of a deboronofluorination pathway will be presented, along with mechanistic
investigation. The synthetic utility of boracarboxylated products to form new carbon-carbon
bonds through cross-coupling afforded 2,3-diarylpropionic acids. This synthetic pathway will
allow for chemoselectivity that is not observed through traditional pathways, such as the
hydrocarboxylation of stilbenes.
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Chapter 1: Introduction

1.1 Converting carbon dioxide into value added products

Catalysis plays a critical role in the development of sustainable chemistry. The use of
catalysts in synthesis is a fundamental component of innovation to further improve eco-efficiency,
economic growth, and our quality of life.1,2,3 The consistent efforts from the scientific community
to develop new catalytic systems and advance methodology continue to economically and
environmentally benefit our society. One way to reduce the environmental impact is to explore the
utilization of biomass as a renewable source of carbon. An established strategy is to use catalytic
processes to convert carbon dioxide (CO2) into synthetically relevant, value added products.4,5
In recent years, there has been increasing awareness of the contribution of greenhouse
gases to global warming. This has caused a redirection to replace steam reforming to dry
reformation, involving the reaction of carbon dioxide with hydrocarbons to product synthesis gas,
a mixture of hydrogen and carbon monoxide.6 An important subsequent product of synthesis gas
is methanol, which can also be produced by the reaction of carbon dioxide with hydrogen gas. The
current demand for methanol is estimated at 30 million metric tons, being employed as a fuel
source.5 A similar methodology of reaction between carbon dioxide and hydrogen gas is used to
produce formic acid, which is used as a preservative, de-icing agent, and in leather tanning.5
One of the oldest industrial processes utilizing CO2 is the synthesis of salicylic acid via the
Kolbe-Schmitt reaction (Scheme 1.1).7 In this process, sodium phenolate reacts with high pressures
of CO2 at high temperatures to yield an excellent ortho-selectivity through the chelation of sodium
ions.5 Carbon dioxide is also used for the industrial-scale production of urea (Scheme 1.2). In 2011,
the annual production of urea was 153 million metric tons while utilizing 112 million metric tons
of CO2 as a feedstock.8 The largest portion of urea is used for agricultural fertilizers; however,
urea finds many diverse applications in emission control of cars and power plants, as a moisturizer
in the pharmaceutical industry, and in the tobacco industry to increase nicotine absorption.5 One
contemporary utilization of CO2 involves the reaction with epoxides to form cyclic carbonates and
polycarbonates (Scheme 1.3).9 Organic carbonates have a wide array of applications in the
production of engineering plastics, as solvents used for lithium ion batteries, and its addition to
gasoline results in an improved octane value. Owing to their high impact-resistance and optical
1

transparency, polycarbonates can be utilized in DVDs, eyeglasses, and aircraft windows.10 This
methodology has even attracted attention to produce Covestro’s Makrolon, which is a highperformance, lightweight, and easy-to-shape plastic.

Scheme 1.1 Industrial process for the formation of salicylic acid

Scheme 1.2 Production of urea

Scheme 1.3 Reaction of epoxides with CO2 to form cyclic carbonates and polycarbonates

1.2 Carboxylation strategies to yield carboxylic acids

The utilization of abundant and inexpensive CO2 has gained tremendous interest as a way
to access carboxylic acids in an atom-economical manner. Carboxylic acids are versatile moieties
in organic chemistry as they are common motifs in a variety of pharmaceuticals and are useful
precursors to access alcohols, esters, and amides. One contemporary organometallic
transformation with CO2 involves the carboxylation of organozinc reagents to yield carboxylic
acids. The transformation is believed to proceed through an oxidative addition of CO2 to Ni(0) to
generate Aresta’s complex followed by transmetalation with the zinc reagent (Scheme 1.4).11
2

Reductive elimination would result in a new carbon-carbon bond, generating a zinc carboxylate
that is hydrolyzed to afford the carboxylic acid product.

Scheme 1.4 Carboxylation of organozinc reagents catalyzed by Aresta’s complex

Two other organometallic pathways to access the carboxylic acid moiety utilize copper catalysis.
Iwasawa reported a copper(I)-catalyzed carboxylation of aryl and alkenyl boronic esters under
mild conditions.12 Another method by Daugulis utilizes copper catalysis to perform the
carboxylation of aryl iodides.13 This process has excellent functional group tolerance with ester,
bromide, chloride, fluoride, ether, amino, hydroxyl, and carbonyl functionalities. (Scheme 1.5).

Scheme 1.5 Mild carboxylation of aryl halides and aryl boronic esters

The carboxylation of alkynes with CO2 could provide industrially relevant acrylic acids
(Scheme 1.6). In 2011, Ma and co-workers developed the first example of a nickel-catalyzed
regioselective hydrocarboxylation. It was the first nickel-catalyzed hydrozincation of alkynes to
3

form syn selective alkenyl carboxylic acids mediated by cesium fluoride.14 It is proposed that the
fluorine source reacts with CO2, increasing the reactivity of the carbon-oxygen double bond.
Another protocol by Tsuji utilized a copper hydride species generated in situ from an Nheterocyclic carbene bound copper fluoride and a hydrosilane, owing to the strong silicon-fluorine
interaction.15 The copper hydride would then undergo insertion with the alkyne and subsequent
reaction with CO2 to afford similar alkenyl carboxylic acids. These previously reported
methodologies led to the development of a hydrocarboxylation strategy that avoided the use of airsensitive or organometallic reagents. The nickel-catalyzed process described by Martin still
demonstrated excellent regioselective alkenyl carboxylic acids using commercially available,
mild, and user-friendly alcohols as the proton source.16

Scheme 1.6 Selected examples of hydrocarboxylation of alkynes

Based on the catalytic systems involving the carboxylation of alkynes, the
hydrocarboxylation of alkenes could also be implemented to achieve pharmaceutically relevant
4

carboxylic acids. The important α-aryl propionic acid pharmacophore is found in many nonsteroidal anti-inflammatory drugs (NSAIDs). In 2001, NSAIDs accounted for 70 million
prescriptions and 30 billion over-the-counter medications used for pain and inflammation.17
Propionic acid derivatives comprise one of the largest class of these pain relievers (Figure 1.1).
Due to their prevalence in pharmaceuticals, there are a number of transition metal-catalyzed
processes to synthesize these moieties. Hydrocarboxylation of vinyl arenes has proven to be a
viable route to access these NSAIDs (Scheme 1.7).

Figure 1.1 Common α-aryl propionic acid non-steroidal anti-inflammatory drugs (NSAIDs)

In 2008, Rovis reported a nickel-catalyzed hydrocarboxylation of vinyl arenes using
diethyl zinc as the hydride source.18 This process is only tolerated for electron-deficient and
electron-neutral styrene derivatives. A few years later, Thomas and co-workers were able to
achieve the hydrocarboxylation of styrene substrates bearing electron-donating substituents.19 This
protocol utilized an iron-catalyzed process starting from an inexpensive, nontoxic, bench-stable
iron precatalyst. Excellent yields with control of regioselectivity were achieved through the use of
a Grignard reagent bearing β-hydrogens. The iron hydride species generated is trapped by an
alkene in a hydrometalation step and then reacted with carbon dioxide. A similar catalytic
transformation uses Cp2TiCl2 as the catalyst and iPrMgCl as the hydride source to gain access to
α-aryl carboxylic acids also bearing electron-donating groups.20

5

Scheme 1.7 Selected examples of hydrocarboxylation of vinyl arenes

Another interesting strategy to achieve these moieties is a hydroboration-carboxylation
methodology. One approach to gain access to α-aryl propionic acids is the generation of benzyl
carbanions from styrenes.21 This route employs a copper-catalyzed Markovnikov hydroboration
of styrenes. Attack of the bulky potassium tert-butoxide base at the boronic ester boron would
generate the boronate that could then undergo heterolytic C-B bond cleavage (Scheme 1.8). The
sterically induced cleavage gives a highly reactive benzyl carbanion that reacts with carbon
dioxide. Another protocol relies on the hydroboration of vinyl arenes using 9-BBN followed by
carboxylation with CO2 using a copper catalyst (Scheme 1.9), similar to Iwasawa’s methodology
described above.22 This chemistry was demonstrated with cyclic olefins, stilbenes, and styrenes.
Terminal alkynes even underwent double carboxylation to produce malonic acid derivatives.

6

Scheme 1.8 Schomaker’s hydroboration/carboxylation strategy

Scheme 1.9 Skrydstrup’s hydroboration/carboxylation strategy

1.3 Hetero(element)carboxylation to afford highly functionalized carboxylic acids

Although hydrocarboxylation of vinyl arenes is a versatile transformation, there are a few
drawbacks. The use of a reactive Grignard or zinc hydride source, as discussed above, results in
limited functional group tolerance. This chemistry also proceeds through a reactive metal-hydride
intermediate that can limit the scope of reactivity. A more appealing transformation includes the
installation of CO2 and another hetero(element) in one step. This method would avoid reactivity
issues previously observed in the hydrocarboxylation systems and install two functional groups in
one step, accessing a more functionalized carboxylic acid product.
Hetero(element)carboxylations have been demonstrated for alkynyl and allenyl substrates
using transition metal-catalyzed processes. Ma reported the first example of an antinucleometallation carboxylation of 2-alkynylanilines using CO2 activation.23 This coppercatalyzed process is an effective strategy to access indolyl-3-carboxylic acids and
indolodihydropyran-2-ones in the presence of dimethylzinc and cesium fluoride (Scheme 1.10).
Utilizing copper catalysis, the silacarboxylation of alkynes was achieved by using a silylborane as
7

the silicon source. The sila-copper complex generated undergoes syn addition to the alkyne
followed by CO2 insertion to afford silalactones in high yield.24 These unsaturated silalactones are
excellent coupling partners under Hiyama cross-coupling conditions. In the same year, there was
another similar difunctionalization with CO2 that was reported. Hou demonstrated the first
catalytic boracarboxylation of alkynes to install Bpin and CO2 moieties across an unsaturated
carbon-carbon triple bond.25 The diborane reagent, B2pin2, was used to access a boryl-copper
complex ligated by a NHC ligand. Subsequent syn insertion of an alkyne into the copper-boron
bond afforded a β-boryl alkenylcopper complex, which was isolated and crystallographically
characterized (Figure 1.2). Nucleophilic addition of this intermediate to CO2 resulted in a cyclic
structure in which the boron atom is bound to the carboxylate unit and the NHC-copper moiety is
bonded to an oxygen atom of the boronic ester group. This structure was revealed through X-ray
crystallographic analysis (Figure 1.2). Transmetalation finally afforded unsaturated boralactonate
salt products.

Scheme 1.10 Hetero(element)carboxylation of alkynes
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Figure 1.2 Crystal structures of the boracarboxylation of alkyne intermediates: alkyne insertion
into Cu-Bpin (left) and CO2 insertion step (right)26

The latter transformation is of particular interest to the Popp group due to the installation
of the boron functionality. Boron has been long overlooked for its use in pharmaceuticals;
however, recently it has gained more attention as an attractive moiety in medicine (Figure 1.3).
Previously, there was a common belief that boron was toxic likely due to the fact that boric acid
is an ingredient in ant poisons.27 Boric acid is also the main ingredient in the children’s toy, Slime,
with a LD50 similar to table salt.28 There is evidence that humans and animals use boron to play a
role in calcium metabolism, bone growth, and insulin metabolism.29 A study in postmenopausal
women showed that by increasing the amount of boron in their diet, it lead to more plasma estrogen
and less calcium excretion, helping with the potential of bone loss.30

Figure 1.3 Boron-containing therapeutics approved by the US Federal Drug Administration
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1.4 Borylcopper-catalyzed borylation reactions

The idea of installing two functional groups in one step and the attractiveness of boron in
organic molecules inspired the Popp group to investigate a transformation involving borylation
chemistry. Borylcopper-catalyzed borylation is a highly effective route to access organoboron
species that can be used for further derivatization in synthesis.31 The first example of an isolated
borylcupration of a carbon-carbon unsaturated bond was reported by Sadighi and coworkers.32 It
was demonstrated that styrene could regioselectivity insert into (IPr)CuBpin to give a β-boroalkyl
complex, which was characterized crystallography (Scheme 1.11). Density functional theory
(DFT) calculations showed that the regioselectivity of the insertion relies on the interaction
between the filled Cu-B σ molecular orbital and the alkene π* molecular orbital.33 This implies
that the strong nucleophilicity of the Cu-B bond and the electrophilicity of the alkene substrate
both need to be considered to understand the regioselectivity observed through experimentation.

Scheme 1.11 Insertion of styrene into (IPr)CuBpin26

This type of alkene insertion into a Cu-Bpin bond is also observed within catalytic systems.
In the same year, Yun and coworkers took advantage of similar chemistry to achieve the
hydroboration of α,β-unsaturated carbonyl compounds.34 The Cu-OtBu pre-catalyst reacts with the
diboron source, B2pin2, to generate the versatile Cu-Bpin intermediate. Syn addition of the
borylcopper to the double bond, followed by protonation by methanol, results in the formation of
the desired hydroboration product and a copper alkoxide (Scheme 1.12). This is an efficient
methodology for conjugate addition to unsaturated carbonyl compounds using catalytic amounts
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of CuCl, NaOtBu, and DPEphos with a cheap, alcohol additive. The first reported example of a
copper-boryl complex used for conjugate addition was described by Miyaura.35 A CuCl/KOAc
and diboron reagent mixture was employed to add a Bpin moiety to an enone in a similar manner.
Hoveyda demonstrated the copper-catalyzed hydroboration of styrene derivatives could be
achieved enantioselectively using a bidentate imidazolinum salt (Scheme 1.13).36

Scheme 1.12 Hydroboration transformation and mechanism using alkene insertion into Cu-Bpin
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Scheme 1.13 Copper-catalyzed enantioselective hydroboration

Another interesting class of reactions known as carboboration involves the copper-boryl
species capturing an alkyl electrophile. High yields have been observed in these cases due to either
a more stable organocopper intermediate, more reactive methyl and benzylic electrophiles, or an
intramolecular alkylation step.37 One protocol relies on the intramolecular alkylation mechanism
to achieve cyclopropane derivatives.38 The selectivity for this reaction is driven by the interaction
between the σ of the Cu-C and σ* of the Si-C orbitals in the copper-boryl addition product (Scheme
1.14). This intermediate undergoes subsequent nucleophilic substitution to afford boron-silicon
difunctional cyclopropanes. The synthetic versatility of these products was also investigated by
subjecting the Bpin moiety to Suzuki-Miyaura cross-coupling conditions and then transforming
the silicon to an alcohol through Tamao oxidation. Yoshida and co-workers also reported an
example of a carboboration of alkenes involving a three component coupling with B2pin2 and an
external carbon electrophile.39 This methodology takes advantage of using a reactive benzyl
chloride electrophile under NHC-ligated copper catalyst conditions (Scheme 1.14). Recently, these
copper-catalyzed alkylborations of alkenes have been extended to provide the first enantioselective
example by Liao and co-workers.40 The alkylboration of styrenes was achieved by utilizing a
chiral sulfoxide phosphine ligand developed in their own lab to install a singularly significant
methyl group (Scheme 1.14). This protocol has proven to be an efficient method for the installation
of a methyl group to achieve high yield and enantioselectivity of the pharmaceutically relevant
NSAID, naproxen, after oxidation conditions. This chemistry also showed success in the late-stage
functionalization of steroid derivatives.
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Scheme 1.14 Selective examples of carboboration utilizing copper-boryl species

Aminoboration is another transformation that utilizes the versatile copper-boryl complex.
The catalytic cycle is similar to carboboration but using an amine electrophile to achieve the
difunctionalization. One example focuses on the reaction of a cyclopropene with a O-benzoylN,N-dialkylhydroxylamine

and

a

diboron

source

to

access

highly

functionalized

cyclopropylboronates (Scheme 1.15).41 The capture of the cyclopropylcopper intermediate with
electrophilic amines is significant due to the importance of cyclopropylamines in biologically
active compounds. This is an interesting methodology to achieve three neighboring stereocenters.
A similar process was carried out by Miura to perform the aminoboration of styrenes 42 (Scheme
1.15). Using the same amine electrophile, B2pin2, and a chiral copper catalyst, the
difunctionalization showed high regio- and stereoselectivity. Miura was also able to expand this
reactivity to demonstrate a ligand-controlled regiodivergent copper-catalyzed aminoboration43
(Scheme 1.15). The xantphos-complexed copper results in the selectivity of the Bpin on the
terminal position and the amino group on the internal position. The opposite regioisomer was
observed under NHC-bound copper conditions. Both methods produce highly functionalized βborylalkylamines.
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Scheme 1.15 Selective examples of aminoboration utilizing copper-boryl species

1.5 Carbon dioxide insertion into alkyl species utilizing copper catalysis

The previous section discussed many examples where alkenes are capable of inserting into
copper-boryl species and then undergoing subsequent trapping with an electrophile to form
difunctionalized products. Using this literature precedent, the Popp group was interested in taking
advantage of this chemistry and partnering it with carboxylation chemistry, which its importance
was described in previous sections of this introduction. Fortunately, there are examples in the
literature where copper species can facilitate carbon dioxide insertion. Sadighi and co-workers
reported a two-coordinate copper complex that could readily insert CO2 into a copper-methyl bond
to form a copper acetate complex.44 This reaction occurred in near-quantitative yield and the
isolated product was characterized crystallography (Scheme 1.16). Another example involves the
carboxylation of alkyl boranes with carbon dioxide.45 The [IPrCu(OMe)] catalyst was mixed with
alkyl borane and an adduct was obtained due to the interaction between the oxygen of the methoxy
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group and the boron atom (Scheme 1.17). When subjected to heat at 70°C under an atmosphere of
CO2, the carboxylate complex was observed in high yield. Both the adduct intermediate and
carboxylate showed high catalytic activity for the carboxylation of alkyl boranes, suggesting that
these are the active catalysts in this system. This fundamental work also confirms that a bonding
interaction between a metal alkoxide and organoboron is a critical step in many of these types of
transition metal-catalyzed processes.

Scheme 1.16 Carbon dioxide insertion into copper-alkyl bond and X-ray structure26

Scheme 1.17 Carboxylation of alkyl boranes with CO2: X-ray structure of alkyl borane adduct
intermediate (left) and CO2 insertion step (right)26
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1.6 Boracarboxylation of vinyl arenes

The Popp group is interested in the utilization of CO2 to generate carboxylic acids,
particularly α-phenyl propionic acids. The importance of this pharmacophore in NSAIDs has
prompted the design of a carboxylation strategy to transform vinyl arenes. With the recent
attractiveness of boron in therapeutics, there is motivation to perform boracarboxylation
difunctionalization chemistry. As discussed in the two previous sections, there is literature
precedent for the insertion of alkenes into Cu-boryl species and insertion of CO2 into Cu-alkyl
complexes. Based on the interests of the Popp group, a mechanism was proposed for the
boracarboxylation of vinyl arenes (Scheme 1.18). The Cu-OtBu pre-catalyst could undergo
methathesis to generate a Cu-Bpin that subsequently inserts the vinyl arene substrate. By
overcoming side pathways of β-hydride elimination and protonation, CO2 could then undergo
insertion into the copper-alkyl. The carboxylate product would be afforded from the
transmetalation with a metal alkoxide to turn over the catalytic cycle.

Scheme 1.18 Proposed mechanism for the boracarboxylation of vinyl arenes

Based on the plausible mechanism described above, the Popp group first sought to screen
copper catalysts that would be able to achieve boracarboxylated styrene as the major product
(Table 1.1).46 One side product could arise by way of protodemetallation of the copper-boryl
insertion intermediate to afford the formal hydroboration product, which is labeled as 2 in Table
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1.1. The other side product observed during screening is due to a β-hydride elimination pathway
from the versatile copper-boryl insertion intermediate, labeled as 3. The first trend observed is that
there is a necessity for an electron-donating ligand complexed to the copper metal. The yield of
desired boracarboxylated product increases as the phosphine has more donating character, which
is observed from exchanging the phenyl groups to alkyl substituents (Table 1.1, entries 1-4). When
attempting to test bisphosphines for catalytic activity (Table 1.1, entries 5-7), the yield is
significantly diminished when compared to the mono-coordinating tricyclohexylphosphine
(PCy3). Based on previous systems in the literature, NHC ligands have also shown success in
similar copper catalysis. When screening NHC ligands (Table 1.1, entries 8-11), the ICyCuCl
achieved a very high yield of boracarboxylated product. The control study was also performed
(Table 1.1, entry 12) to confirm a ligand is necessary for the catalysis to occur.

Table 1.1 Copper catalyst optimization for boracarboxylation of vinyl arenes
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After optimization of the catalyst system and reaction conditions, the scope of the reaction
was investigated. The boracarboxylation of vinyl arenes tolerated a number of styrene derivatives,
as shown in the abbreviated substrate scope, Table 1.2. The catalysis was successful with substrates
bearing a donating group in the para position such as the tert-butyl, methyl, methoxy, phenoxy,
protected amide, naphthyl, and isobutyl groups. The reaction showed good yield for the slightly
electron-withdrawing fluorostyrene. When extending the substrate scope to meta- and orthosubstituted styrenes, the yield diminished, which is demonstrated with the para-, meta-, and orthofluoro derivatives in Table 1.2. Unfortunately, the reaction did not tolerate electron-withdrawing
groups, as observed with the para-trifluoromethyl analogue.

Table 1.2 Representative examples of boracarboxylation substrate scope
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Due to the high yield and ease of purification, a gram-scale boracarboxylation of the tertbutylstyrene was carried out (Scheme 1.19). The ability to scale up the reaction would be necessary
to demonstrate the relevance of these products in a pharmaceutical application. It is also important
to perform this transformation on a larger scale to explore its synthetic utility. The crystallization
of the tert-butyl analogue afforded the crystal structure to confirm the regioselectivity of the
carboxylic acid and Bpin moieties (Figure 1.4, Appendix I).

Scheme 1.19 Gram-scale boracarboxylation of tert-butylstyrene

Figure 1.4 X-ray crystal structure of boracarboxylated tert-butylstyrene

Based on the preliminary findings for the boracarboxylation of vinyl arenes, the following
chapters will detail the ability to lower catalyst loading in this catalytic system, expansion of
substrate scope, and synthetic utility of the products.
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Since our publication, hetero(element)carboxylations have been achieved through visiblelight photoredox catalysis. This area of research highlights the versatility and utility of the
hetero(element)carboxylation of alkenes. The Martin group demonstrated a catalytic
intermolecular dicarbofunctionalization of styrenes with the use of CO2 under blue-light emitting
diode (LED) irradiation.47 This provides a mild protocol to install a trifluoromethyl group and
carboxylic acid moiety in one step (Scheme 1.20). In the same year, Yu published an ironpromoted methodology to achieve the first example of thiocarboxylation of styrenes and
acrylates.48 These β-thioacids were produced in the opposite regioselectivity that is commonly
observed in these systems with the carboxylic acid installation in the terminal position (Scheme
1.20). Only one year later, a similar process used a visible-light promoted and metal-free
difunctionalization to achieve a silacarboxylation of alkenes. 49 Through the combination of
photoredox and hydrogen-atom transfer catalysis, a number of β-silacarboxylic acids are directly
accessed from simple alkene starting materials (Scheme 1.20).

Scheme 1.20 Hetero(element)carboxylation of alkenes utilizing photocatalysis
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Chapter 2: Effect of Triphenylphosphine Additive in Boracarboxylation of Styrene
Derivatives

2.1 Introduction
As described in Chapter 1, the boracarboxylation of vinyl arenes is an attractive
transformation that can be used to access novel α-aryl-β-boryl propionic acids. There are a number
of economic and environmental benefits of this difunctionalization. The reaction employs easily
accessible, abundant, and cheap styrene substrates. The diboron reagent, B2pin2 is stable and easy
to handle. This protocol also exploits a recyclable, abundant electrophilic carbon source of carbon
dioxide to synthesize highly functionalized carboxylic acid derivatives with minimal amount of
undesirable by-products. Although utilizing a NHC-stabilized base-metal catalyst system, one
drawback of this new methodology was the high catalyst loading (12 mol%) necessary for the
reaction to occur (Scheme 2.1).

Scheme 2.1 Popp’s copper-catalyzed boracarboxylation of vinyl arenes

In the same year, there was a methodology published by Buchwald that examined the
reductive coupling of styrene and benzoic anhydride to yield chiral alcohol products.50 The copper
catalyst system initially employed the chiral (S)-DTBM-SEGPHOS phosphine ligand to achieve a
25% yield of desired product (Table 2.1). The monoaryl bisphosphine (R,R)-Me-DuPhos increased
the yield to 45%; however, the stereoselectivity was drastically diminished. The trialkyl
bisphosphine (S,S)-Ph-BPE increased the yield to 77% with high selectivity. By addition of the
secondary ligand, PPh3, the reaction was driven to very high yield and selectivity. Buchwald also
demonstrated this same effect in the enantioselective Cu-H catalyzed synthesis of 2,3-disubstituted
indolines51 and the enantioselective Cu-H catalyzed hydroamination of 1,1-disubstituted alkenes.52
In these examples, the addition of PPh3 as a secondary ligand improved catalytic turnover without
impacting enantioselectivity, which allowed for reduced loadings of copper and ligand. This
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phenomena was first observed by Lipshutz and co-workers.53, 54 In the asymmetric hydrosilylation
of aryl ketones catalyzed by Cu-H, the addition of an equivalent of PPh3 was shown to help
maintain the lifetime of copper hydride. It was shown that the “trick” of storing Cu-H by inclusion
of PPh3 derives from the fact that (Ph3P)CuH itself cannot compete with the ligand-accelerated
catalysis. We hypothesized that we would be able to take advantage of this secondary ligand effect
to lower the copper catalyst used in the boracarboxylation of vinyl arenes.

Table 2.1 Addition of PPh3 for enantioselective reductive coupling of aryl alkenes and activated
carboxylic acids

Ligand

Yield (%)

ee%

DTBM-SEGPHOS

25

-95

Me-DuPhos

45

7

Ph-BPE

77

94

Ph-BPE + PPh3

91

94
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2.2 Results
2.2.1 Optimization of employing a secondary ligand in boracarboxylation

Owing to its previous high yielding boracarboxylation, para-tert-butylstyrene was used as
our model substrate for investigating the ability to reduce catalyst loading with the addition of a
secondary phosphine ligand. The previous copper catalyst system employed a strongly sigma
donating N-heterocyclic carbene copper (I) source at a 12 mol% loading to achieve a high yield of
boracarboxylated product with minimal side products (entry 1, Table 2.2). This catalysis can also
be achieved at the same yields in only 6 hours. Attempting to lower the ICyCuCl catalyst loading
to 5 mol% without a secondary ligand, resulted in a lower yield of desired product (entry 2, Table
2.2). We reasoned that the ICyCuCl catalyst was decomposing to an inactive species, promoting
formation of unwanted borylation side products as well as polymerization as evidenced by near
quantitative styrene conversion. When screening PPh3 as a ligand with copper (I) chloride,
reactivity to give our desired boracarboxylated product (2b) was considerably diminished (entry
3, Table 2.2). Gaining inspiration from the literature, we sought to reduce catalyst loadings of the
active ICyCuCl catalyst by incorporating a secondary phosphine ligand for the difunctionalization
of vinyl arenes. To our delight, when decreasing the ICyCuCl catalyst to 5 mol% with an addition
of 5 mol% of PPh3, the yield of boracarboxylated product was comparable to yields achieved with
higher catalyst loading (entry 4, Table 2.2). Based on these results, we recognize that the PPh3
ligand with the copper (I) salt cannot itself be responsible as the active catalyst in this
transformation; however, at reduced catalyst loadings, the phosphine must play a role in helping
to stabilize a copper species to accomplish high yields of boracarboxylation. Other sources of
exogenous secondary ligand were also screened. The addition of P(OPh)3 resulted in a reduced
yield of boracarboxylation and a much higher amount of a formal hydroboration side product, 3b
(entry 5, Table 2.2). The addition of a more electron-rich phosphine additive, PCy3, did show
similar reactivity to utilizing PPh3 as an additive (entry 6, Table 2.2). The addition of pyridine,
which showed no reactivity as the primary ligand, was tolerated in the reaction but did not show a
similar stabilizing role as the PPh3 and PCy3 ligands (entry 7, Table 2.2). Addition of excess PPh3
resulted in similar reactivity as having equivalent amounts of copper catalyst and secondary ligand
(entry 8, Table 2.2). When attempting to further decrease the ICyCuCl loading, a 4-fold excess of
exogenous PPh3 was necessary to achieve a moderate yield of 2b (entry 9, Table 2.2). Finally,
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attempting to decrease the ICyCuCl and phosphine loading while applying heat to the reaction
resulted in a lower yield of boracarboxylated product, higher yields of the undesired side products,
and in the latter case, lower conversion of styrene (entries 10-11, Table 2.2). The control
experiment in the absence of copper resulted in no reactivity (entry 12, Table 2.2).

Table 2.2 Optimization of boracarboxylation of vinyl arenes with secondary ligand additiona

2.2.2 Substrate scope of employing a secondary ligand in boracarboxylation
With our optimized conditions at hand, we sought to revisit the vinyl arene substrate scope
that was previously reported. We have shown the yields for the boracarboxylation of vinyl arenes
comparing the 12 mol% ICyCuCl catalytic condition to the 5 mol% ICyCuCl and 5 mol% PPh3
catalyst system. The unsubstituted and alkyl substrates (styrene, para-tert-butyl, para-methyl, and
para-isobutyl styrenes) demonstrated comparable yields of boracarboxylated products (2a-2d) in
both catalyst systems (entries 1-4, Table 2.3). The crystal structure of the isobutyl substrate, 2d,
confirms the regioselectivity of the important bora-ibuprofen NSAID derivative, shown in Figure
2.1 (Appendix I). The electron-donating para-methoxystyrene (2e) was also tolerant to these
reduced catalyst loading conditions (entry 5, Table 2.3). The N-methyl amide (2f) resulted in a
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relativity much higher yield in the case with lower catalyst loading (entry 6, Table 2.3). Similar
reactivity was observed with the para-, meta-, and ortho fluorostyrene (2g-2i) derivatives when
comparing the two catalytic conditions (entries 7-9, Table 2.3). It should be noted that the metaand ortho- substituents were heated to an elevated temperature under both catalytic systems.
Similar yields were also obtained when 12 mol% of PPh3 was added to 12 mol% of ICyCuCl for
the meta- and ortho- fluorosubstituted styrenes. This led to using 2 equivalents of styrene at the
lower catalyst conditions at elevated temperature (entries 8-9, Table 2.3) Another common NSAID
pharmacophore was prepared with bora-naproxen (2j) achieving an increased yield under the
reduced copper catalyst conditions (entry 10, Table 2.3). It can be observed that the isolated yields
for the PPh3 additive conditions resulted in upwards of a 20% decrease from the NMR yields. We
believe this is due to the presence of the phosphine ligand in our multi-step extraction method for
purification.

Table 2.3 Comparison of 12 mol% ICyCuCl and 5 mol% ICyCuCl + 5 mol% PPh3 catalyst systems
for previously reported vinyl arene boracarboxylation
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Figure 2.1 X-ray crystal structure of boracarboxylated isobutyl styrene, 2d

Other than being able to demonstrate similar reactivity with reduced catalyst loadings,
another objective of our research in this area was the ability to expand the substrate scope of this
transformation. Previously, we were unable to achieve boracarboxylation with vinyl arenes
bearing electron-withdrawing groups. To our surprise, we were able to access the
boracarboxylation of the electron-poor para-trifluoromethylstyrene (p-CF3) through excess
addition of styrene. We originally screened this reaction using high loadings of p-CF3 styrene (5
equiv) and ICyCuCl catalyst (12 mol%), as shown in Entry 1, Table 2.4. We were pleased to
observe 40% of the desired boracarboxylation product, 2m. When reducing catalyst loading to 5
mol% with the addition of 5 mol% PPh3, the yield of 2m decreased while the formal hydroboration
side product, 3m, increased (entry 2, Table 2.4). Heating the reaction to 40°C did seem to improve
the product distribution at lower catalyst loading (entry 3, Table 2.4). Ultimately, we observed that
the 5 equivalents of styrene could be reduced to 2 equivalents to achieve comparable yields, with
and without heating the reaction (entries 4-5, Table 2.4). By increasing the catalyst system to 12
mol% ICyCuCl with the addition of 12 mol% PPh3 secondary ligand, we could obtain 2m at a 53%
yield with much lower yields of 3m and at reduced styrene equivalence (entry 6, Table 2.4).
Finally, we also showed the ability to access 2m by using PPh3 as an additive with 1 equivalent of
styrene (entry 7, Table 2.4).
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Table 2.4 Optimization of boracarboxylation for vinyl arenes bearing electron-withdrawing groups

While investigating reactivity of electron-withdrawing styrene derivatives, we have also
achieved catalysis for a new group of substrates that were previously not accessed. The borafenoprofen (2k) and bora-flurbiprofen (2l) substrates have been added to our library of boraNSAID derivatives (Table 2.5). This class of compounds are extremely important as there have
been recent discoveries of boron’s efficacy in medicine.27 By increasing the equivalence of
styrene, as discussed above, we were able to achieve the boracarboxylated product of electrondeficient para-trifluoromethylstyrene (2m) and para-cyanostyrene (2n). The para-acetoxy
substrate (2o), which was also previously unable to be accessed, was attained with our new
catalytic system employing PPh3 as a secondary ligand. Other electron-deficient/sterically
demanding styrene derivatives still proved to be problematic in achieving catalysis, even at
increased styrene equivalents and elevated temperature. The penta-fluorostyrene (2p) and parachlorostyrene (2q) resulted in a poor crude yield (~10%) for boracarboxylation, which could not
be isolated. With these substrates, the NMR analysis showed unreacted starting material and
formal hydroboration product. These are the other two major species observed in the
boracarboxylation of styrenes bearing electron-withdrawing substituents. Finally, the para-nitro
(2r) and para-bromo (2s) substrates did not show any catalytic activity at higher equivalence, with
and without the addition of PPh3. The para-nitro is the strongest electron-withdrawing substituent
that was tested and the para-bromostyrene could possibly be undergoing some oxidative chemistry.
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Table 2.5 Expanded substrate scope for boracarboxylation with use of PPh3 additive catalyst
systema

Along with substrate scope, we wanted to demonstrate the ability to run these lower catalyst
loading reactions on a larger scale. The vinyl naphthalene substrate (1t), which was reported in the
initial boracarboxylation results, showed that the transformation could be increased by a 10-fold
scale. The larger scale resulted in a good yield of 65% of boracarboxylated vinyl naphthalene, 2t
(Scheme 2.2). The ability to increase the scale of these reactions at lower catalyst loading was
extended further to investigate multi-gram reactivity. The versatile tert-butyl substrate was reacted
at an 80-fold scale to access 3.85 g of boracarboxylated product (Scheme 2.2). Our lab has also
shown the ability to run this same reaction at a 160-fold scale to access 8.1 g of product, which is
slightly above a 60% yield. Although the yield of this product is typically much greater, we
attribute the reduced isolated yield to the added challenge of removing PPh3 from the reaction. The
ability to run these reactions on multi-gram scale is important not only from a pharmaceutical
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perspective, but it is also useful to access large amounts of product to test for its synthetic utility.
Subsequent reactivity of these products will be discussed in chapters 3 and 4 of this report.

Scheme 2.2 Scale-up boracarboxylation reactions employing a secondary ligand

2.2.3 Preliminary investigation of role of PPh3
Due to the reactivity observed at lower ICyCuCl loading with the addition of a secondary
phosphine ligand, we wanted to explore the potential role of PPh3 in the catalytic cycle of
boracarboxylation. In order to gain insight into its role, each step of the proposed mechanism
(Scheme 1.18) was investigated. The first series of experiments involve probing the generation of
copper tert-butoxide and metathesis steps by screening different tert-butoxide bases at 12 mol%
ICyCuCl and 5 mol% ICyCuCl + 5 mol% PPh3 catalyst conditions, shown in Table 2.6. It was
observed that under both catalytic systems, the reactivity was comparable whether using LiOtBu,
NaOtBu, or KOtBu as the base. Although there was no significant difference between the two
catalytic systems, employing sodium tert-butoxide as the base resulted in the highest yield of
boracarboxylated product. Yields for potassium tert-butoxide were only slightly decreased;
however, the reactions showed minimal amount of 2b with lithium tert-butoxide (Table 2.6). The
next series of experiments were conducted to probe the generation of the Cu-Bpin species and
subsequent alkene insertion. To gain insight into these steps in the mechanism, order of addition
experiments were performed such as reactions involving PPh3 addition to the catalyst/base solution
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vs. addition to the styrene/B2pin2 solution. Other reactions involved the addition of the PPh3 at later
time intervals after reaction initiation. All of these reactions exhibited comparable
boracarboxylation yields so there is no apparent evidence that PPh3 plays a role in the generation
of copper tert-butoxide, generation of Cu-Bpin, insertion of styrene, or metathesis.

Table 2.6 Screening of bases to determine role of PPh3 in boracarboxylation

In order to study the potential effect of PPh3 on the CO2 insertion step, we used the transβ-methyl styrene to probe reactivity. Despite the syn addition of the Cu-Bpin, two diastereomers
of the boracarboxylated product are observed, as shown in Table 2.7. The syn diastereomer, 2v,
would be achieved via stereoretentive CO2 insertion into the Cu-alkyl bond. The anti diastereomer,
2v’, would result from a stereoinvertive SE2 type pathway. When 12 mol% ICyCuCl was employed
as the catalyst, a diastereomeric ratio of 7:1 syn:anti was observed (Table 2.7). Due to the steric
hindrance of the methyl in the beta position, this substrate can only be afforded at high catalyst
loading, elevated temperature, and increased reaction scale. When an additional 12 mol% of PPh3
secondary ligand is added to the reaction, 2v is still favored; however, the ratio is reduced to 2:1
(Table 2.7). This has lead our group to believe that PPh3 has an effect on the CO2 insertion step.
There is also literature precedent that this is a viable hypothesis. In 2016, Hou and co-workers
reported a copper-catalyzed coupling of carbon dioxide, diboron, and aldehydes.55 In the report,
the authors marveled at the ability to selectively and efficiently achieve catalysis even though a
number of side reactions could be possible. One major side reaction mentioned involves the
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carboxylation of the copper tert-butoxide with CO2. This transformation had been investigated by
Saegusa and co-workers over 30 years prior.56,57 This work describes carbon dioxide insertion into
copper tert-butoxide to form carbonate species in the presence of a series of ligands, specifically
PPh3. As shown in Scheme 2.3, these species are referred to as reversible carbon dioxide carriers.
At present, our group believes that the addition of PPh3 is involved in this CO2 insertion process.
Future investigation from our group will explore the potential formation of carbonates in the
catalytic process. We are also interested to study the effect PPh3 has on reaction kinetics.

Table 2.7 Investigation of role of PPh3 in CO2 insertion step

Scheme 2.3 Carboxylation of copper tert-butoxide in presence of PPh3 ligand

2.2.4 Investigation of reactivity for boracarboxylation
Given the ability to expand upon the previously explored substrate scope, we sought to
gain more insight into reactivity. It was demonstrated through stoichiometric reactivity by Sadighi
that more electron-deficient styrenes insert copper-boryl species at a faster rate than electron-rich
styrenes.32 This was an interesting piece of data considering we had just recently gained access to
the boracarboxylation of electron-withdrawing substrates. When performing the competition
experiment between the electron-rich para-tert-butylstyrene (1b) and slightly electron31

withdrawing para-fluorostyrene (1g), the yields of boracarboxylation are higher for the parafluorostyrene, which may be the result of a favorable insertion (Table 2.8). This data also shows
as the amount of PPh3 is increased, the yield of boracarboxylation also increases. The 5 mol%
ICyCuCl loading resulted in similar yields of 2g regardless of the increasing PPh3 concentration.
This trend revealed that the favorable insertion of 1g followed by carboxylation seemed to peak at
a yield of around 37%. As more phosphine is added, the boracarboxylation of tert-butylstyrene
increased, resulting in an increased overall yield of the two products (Table 2.8). The increase in
2b as more PPh3 is added matches the previous results that PPh3 with CuCl can be utilized as a
catalyst to achieve a minimal amount of boracarboxylated product (~20%). This data shows that
the insertion of fluorostyrene into the copper-boryl species achieves a maximum yield and then
the electron-donating styrene undergoes insertion/carboxylation until an equal amount of both 2b
and 2g exists. In the final entry, 12 mol% ICyCuCl is employed as the catalyst system and the
results resemble a similar product distribution as the 5 mol% ICyCuCl, albeit in higher yields due
to the increased loading.

Table 2.8 Competition studies between para-tert-butylstyrene and para-fluorostyrene

32

In the competition experiment between para-tert-butylstyrene and para-fluorostyrene, there
is a significant increase in the overall yield of the two boracarboxylated products when the copper
catalyst was altered from 5 mol% ICyCuCl + 5 mol% PPh3 to 12 mol% ICyCuCl. This is surprising
because both catalytic systems seemed to perform more similarly in the substrate scope
investigation. We believe this observation is attributed to the nature of the competition between
the two styrenes at the different active catalyst loading. When styrene (1a) and para-fluorostyrene
(1g) were added in the same reaction, the boracarboxylated styrene (2a) was achieved in a slightly
higher yield than 2g (Table 2.9). The yields of 2a and 2g were achieved in similar yields under
both catalytic systems, which is different from what was observed in the para-tert-butylstyrene vs.
para-fluorostyrene competition study. We believe this reactivity can be attributed to the fact that
styrene and para-fluorostyrene have very similar Hammett σpara constants of 0.00 and 0.06,
respectively.58

Table 2.9 Competition studies between styrene and para-fluorostyrene

Because we have performed the competition experiment between two electronically similar
styrenes, we also sought to run the competition experiment between the electron-rich para-tertbutylstyrene that has a Hammett σpara value of -0.20 and the electron-deficient paratrifluoromethylstyrene with a value of 0.54. When carrying out the reaction with both styrenes
added, only boracarboxylated product for the para-trifluoromethylstyrene, 2m, was observed
(Table 2.10). This could be explained by competitive binding/insertion of the much more electron33

deficient styrene, which could prevent the insertion of the electron-rich styrene. When the lower
copper loading with secondary PPh3 was employed as the catalyst system, the yield of 2m was
significantly reduced. This may be due to the fact that only one equivalent of 1m, with respect to
B2pin2, was added and that higher catalyst loading is needed to generate a more nucleophilic
intermediate for carboxylation to occur. We also demonstrate that when the amount of 1b is
reduced to 0.025 mmol or 10%, reactivity is decreased but the p-CF3 substrate still shows catalytic
turnover (Table 2.10). When the boracarboxylation of 1m was conducted at low styrene loading
without the presence of another styrene (Table 2.11), boracarboxylated product was produced in
minimal yields. Based on this data and preliminary stoichiometric experiments, we realize that
even a catalytic amount of another electron-donating styrene will result in boracarboxylated p-CF3
substrate. Although it seems as no insertion of the para-tert-butylstyrene occurs, its presence in the
reaction and potential binding to copper increases the yield of 2m. Stoichiometric reactivity and
Hammett studies conducted in our group show a negative ρ value for the carboxylation step in our
proposed mechanism. Due to our previous challenges in accessing boracarboxylation with
substrates bearing an electron-deficient substituent, we believe that the slow step in our reaction
is the carboxylation step. This also makes sense based on the fact that our group, along with
Sadighi, observe that insertion of electron-deficient styrenes occurs at a faster rate.

Table 2.10 Competition studies between para-tert-butylstyrene and para-trifluoromethylstyrene
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Table 2.11 Boracarboxylation of para-trifluoromethylstyrene at low styrene loading

2.2.5 Investigation of proton source for protoboration by-product
One observation that was mentioned above while exploring the substrate scope of
boracarboxylation with addition of PPh3 was that the electron-deficient substrates showed a
relatively high amount of formal hydroboration by-product, 3m. This is observed in the screening
of electron-deficient p-CF3 styrene (Table 2.4). This product was also observed in the competition
studies between p-tBu and p-CF3 styrenes. Highlighted in Table 2.12, 3m resulted in a relativity
high yield compared to the amount of 2m. Based on the proposed mechanism, this product arises
from the insertion of alkene into the Cu-Bpin species, which is then trapped with a proton source,
inhibiting the carboxylation step. This is a viable route, particularly because the carboxylation step
is challenging with electron-deficient arenes. A major question that arises in these cases is the
source of the proton in this reaction. Based on our observations, we sought to devise a series of
experiments to determine the origin of the proton to result the protoboration side product.
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Table 2.12 Competition studies between para-tert-butylstyrene and para-trifluoromethylstyrene
with para-trifluoromethylstryene protoboration product

The first experiment performed to determine the source of proton, affording the
protoboration product, was to utilize deuterated styrene. In the case of achieving boracarboxylation
of electron-deficient substrates, it has been shown that additional equivalents of styrene can be
added to the reaction to achieve higher yields. Because of this, we hypothesize that the source of
proton may arise from the additional styrene present in the reaction. To test this theory, the
boracarboxylation between 1a and 1m was performed as a control experiment (Scheme 2.4).
Similarly to other competition experiments with p-CF3 styrene, there was no boracarboxylation of
styrene (2a); however, there was a 30% yield of 2m and a 21% yield of 3m. When testing with
deuterated styrene, 1a’, similar yields of 2m and 3m were observed (Scheme 2.4). There was also
no deuterium incorporation into the protoboration product in the case of cross-over. The deuterium
NMR only showed signals in the aromatic and vinyl regions, which would match left over
deuterated styrene.
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Scheme 2.4 Boracarboxylation reaction between styrene vs. para-trifluoromethylstyrene (top) and
deuterated styrene vs. para-trifluoromethylstyrene (bottom) to test for proton source in
protoboration by-product

Another hypothesis is that the proton arises from producing a source of HBpin, which could
then generate a copper hydride species. To test this possibility, a mixture of B2pin2 and HBpin
were used as the boron source in varying equivalents in the boracarboxylation of 1b (Table 2.13).
The data from these experiments show that boracarboxylation still occurs only when B2pin2 is
present and 3b was not detected in any of the reactions in this series (Table 2.13). Although it
seems that the proton is not due to a source of HBpin in the reaction, we were able to provide
evidence that HBpin is not even reactive in the catalytic cycle. When B2pin2 and HBpin were both
added in equimolar amounts (0.55 equiv), the yield of 2b was 42%, which seems to be the result
of using only a half of an equivalent of B2pin2, the active Bpin source. Similarly, when only 0.275
equiv of B2pin2 was used in the reaction, a 22% yield of 2b was achieved. Finally, when only
HBpin was used, there was no presence of 2b or 3b. Due to the observation that electron-rich
substrates afford little to no protoboration product, a similar experiment was conducted in the case
of boracarboxylation of p-CF3 to determine whether more protoboration product, 3m, was
observed when adding HBpin to the catalytic system. As observed in Scheme 2.5, when 0.5 equiv
of B2pin2 and 0.5 equiv of HBpin were utilized, there was only a 15% yield of 2m. This data is in
agreement because it is about half the yield of a boracarboxylation with “normal” conditions
utilizing 1.1 equiv of B2pin2. There is also minimal amount of 3m observed, which has led us to
believe that HBpin is not an active source of Bpin and it is not the origin of proton in this
transformation.
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Table 2.13 Investigation of HBpin as boron source in boracarboxylation

Scheme 2.5 Boracarboxylation of p-CF3 styrene with excess p-tBu styrene and HBpin as a boron
source
Although the protoboration product is made in predictable yields depending on the
conditions, we also sought to perform a type of control experiment by adding a small (ppm)
amount of water to determine if the protoboration was arising from residual water during the
reaction. In order to perform this control, we simply added 1-2 ppm of D2O after reaction initiation
and looked for evidence of deuterium incorporation at the benzylic position. As shown in Scheme
2.6, an equivalent amount of 2m and 3m were obtained, which is typical with this substrate. More
importantly, there was no evidence of deuterium incorporation at the benzylic position (3m’). In
the 1H NMR spectrum, the benzylic proton still showed a broad triplet pattern and the 2H NMR
spectrum only showed deuterated CDCl3, which the sample was dissolved in.
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Scheme 2.6 Boracarboxylation of p-CF3 styrene with addition of D2O to reaction

One hypothesis was that the hydroboration of styrene could be competitive under the
boracarboxylation reaction conditions. In a recent report, Fernandez demonstrated a metal-free
diboration of alkenes.59 The diboron reagent can be activated by alkoxides60 to increase the
nucleophilic character of the trivalent boryl and subsequently force the olefin to act as an
electrophile to achieve diboration. This methodology showed a substrate scope limitation where
vinyl arenes only resulted in the hydroborated product (Scheme 2.7). The phenyl substituent of the
alkene stabilizes the negative charge at the internal carbon, which can favor the hydroboration
over diboration. Because the boracarboxylation conditions include a diboron reagent and a tertbutoxide base, we believed that we could potentially be undergoing a metal-free hydroboration of
styrene derivatives. In order to test this hypothesis, we performed a reaction with 2 equivalents of
1m and base, with respect to our diboron reagent, similar to our normal reaction conditions
(Scheme 2.8). We omitted the copper catalyst and CO2 because the reaction should result from a
base-catalyzed process in which the CO2 electrophile is not necessary. At the end of the reaction,
we only observed styrene, B2pin2, and tert-butoxide starting material signals in the 1H NMR. These
results have lead us to believe that if there is a competitive hydroboration side pathway, it is not a
base-catalyzed process.
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Scheme 2.7 Metal-free boration of styrene

Scheme 2.8 Boracarboxylation of p-CF3 styrene without copper catalyst and CO2 to test for basecatalyzed hydroboration

One last investigation of the source of proton was to study the protonation step. It could be
proposed that diboration could be achieved and then the bulky tert-butoxide base could initiate a
sterically induced cleavage (Scheme 1.8) that is then protonated. The boracarboxylation of 1m was
conducted under normal reaction conditions with DCl and D2O used in the work-up (Scheme 2.9).
This same reaction was also attempted without the copper catalyst and carbon dioxide. In both
cases, there was no deuterium incorporation observed. Specifically, no alkyl deuterium peaks were
observed in the 2H NMR spectra.

Scheme 2.9 Boracarboxylation of p-CF3 styrene using DCl and D2O in the work-up step
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2.3 Conclusion
In summary, we have developed a catalyst system that allows for a reduced loading of
copper with the use of a secondary PPh3 ligand. With this system, we were able to demonstrate the
ability to achieve similar yields of some previously reported substrates. Access to the
boracarboxylation of electron-deficient substrates was also achieved through additional
equivalents of styrene. Preliminary experiments have been conducted to test the role of PPh3 in the
catalytic cycle. Competition studies have revealed that electron-deficient substrates actually
undergo insertion at a faster rate, which is in agreement with the literature. We attribute the
challenge of boracarboxylation of electron-deficient substrates to be due to a slow CO2 step, which
can be overcome by the presence of electron-donating styrene. Finally, experiments have been
conducted to probe the source of proton, resulting in the relatively high amounts of protoboration
product with electron-deficient substrates.

2.4 Experimental Methods
2.4.1 General information
Due to air and moisture sensitivity, all experiments were set up in a nitrogen-filled MBraun
200B dual-port glovebox. Dry tetrahydrofuran was used for all experiments from a Glass Contour
solvent purification system and the deuterated CDCl3 was purchased from Cambridge Isotope
Laboratories, Inc. NMR spectra were recorded on either a 400 MHz Agilent or a 400 MHz JEOL
NMR spectrometer. 1H NMR experiments were run in CDCl3 using tetramethylsilane as an
internal standard and 13C NMR spectra used CDCl3 as a solvent and reference. 19F and 11B NMR
experiments were also run in CDCl3 with 11B NMR spectra recorded using quartz NMR tubes and
referenced to an external BF3·OEt2 standard. High-resolution mass spectra were recorded on a
Thermo Fisher Scientific Q Exactive Mass Spectrometer dissolving our samples in 1:1
methanol/acetonitrile. The N-methyl-4-vinylacetanilide substrate was prepared based on previous
literature methods.61 The 4-isobutylstyrene and 3-phenyoxystyrene substrates were synthesized by
subjecting the aldehyde precursor to Wittig conditions. The 2-methoxy-6-vinylnaphthalene and 3fluoro-4-phenyl styrene substrates were prepared by performing Suzuki cross-coupling from the
commercially available bromide compounds with vinyl-Bpin. All other substrates were
commercially available styrene derivatives.
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2.4.2 Experimental procedures
The procedure and characterization of the ICyCuCl complex were based on literature
precedent.62 In a nitrogen-filled glovebox, a vial was charged with ICyCuCl (4.0 mg, 0.012 mmol,
5 mol%), PPh3 (3.0 mg, 0.011 mmol, 5 mol%), sodium tert-butoxide (48.0 mg, 0.50 mmol, 2.0
eq.), and anhydrous, degassed THF from the solvent system (0.90 mL). The vial was sealed and
stirred for at least 15 minutes to afford a clear, pale yellow solution. In a separate 25 mL roundbottom flask, bis(pinacolato)diboron (70.0 mg, 0.275 mmol, 1.1 eq.) and 3.1 mL of THF were
added. To the solution, vinyl arene (0.25 mmol, 1.0 eq.) was added. The flask was charged with a
stir bar, sealed with a septum, and taped. The catalyst solution in the vial was pulled up in a 1.0
mL syringe and the needle with capped into a septum. The syringe containing catalyst solution
and the 25 mL round-bottom flask containing vinyl arene were taken out of the glovebox. The
catalyst/base solution was added to the round-bottom and the vessel was fitted with a doublewalled CO2 balloon. The reactions were stirred at room temperature for 36 hours, replacing the
balloons when deflated. With the substrates bearing electron-withdrawing groups, as reported
above, the amounts of bis(pinacolato)diboron (63.0 mg, 0.25 mmmol) and vinyl arene (0.50 mmol,
2.0 eq.) were altered. These reactions bearing electron-withdrawing vinyl arenes were also heated
to 40°C. Upon reaction completion, the reaction was quenched with 20 mL of 1.0 M aqueous HCl
and extracted with dichloromethane (15 mL x 3). The combined organic layers were collected in
a 100 mL round-bottom flask and concentrated under vacuum to give the crude product.
Mesitylene (20 mol%) was added to the crude mixture as an internal standard and dissolved in
CDCl3 to be analyzed by 1H NMR. If boracarboxylated product was present in NMR, the crude
product was taken up in 6 mL of diethyl ether and extracted with saturated NaHCO3 (6 mL x 3).
The combined aqueous layers were collected in a 50 mL Erlenmeyer flask and acidified with 12
M HCl. The product was transferred to a separate separatory funnel and extracted with
dichloromethane (15 mL x 3). The combined organic layers were dried over sodium sulfate,
filtered, and dried under vacuum to afford the boracarboxylated product. NMR characterization
data was carried out on purified compound, along with high-resolution mass spectroscopy for new
compounds. For the competition experiments between para-tert-butylstyrene and parafluorostyrene, mesitylene (20 mol% with respect to B2pin2) was used as the internal standard in
1

H NMR to determine total yield of boracarboxylated product. Fluorobenzene (20 mol% with

respect to B2pin2) was used as the internal standard in

19

F NMR to determine the yield of
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boracarboxylated para-fluorostyrene. The difference between the two values provided the yield of
the boracarboxylated para-tert-butylstyrene. This method was used due to overlapping methine
and methylene product peaks. In the case of the competition studies performed between paratertbutyl styrene and para-CF3 styrene, there is only para-CF3 boracarboxylation product observed.
When using mestiylene in 1H NMR and fluorobenzene in

19

F NMR to confirm integration

accuracy, the yields in both spectra were within integration error of each other (<5%), making this
a viable method for yield determination. All competition studies were ran at a slightly shorter
reaction time of 24 hours. Preliminary experiments to investigate the role of PPh3 or to determine
source of proton in protoboration side product may have had slightly different conditions, which
are noted in the text and schemes above.

2.4.3 Characterization of isolated compounds
1

H,

13

C,

11

B, and

19

F NMR shifts for compounds 2a-2j and 2t matched our previously reported

results.42 All NMR spectra can be found in Appendix II.

3-boronic acid pinacol ester-2-phenyl propionic acid 2a. white solid, yield 75%
1

H NMR (400 MHz, CDCl3): δ 7.30 – 7.22 (m, 5H), 3.86 (dd, J = 9.4, 7.4 Hz, 1H), 1.55 (dd, J =

16.0, 9.3 Hz, 1H), 1.29 (dd, J = 16.0, 7.4 Hz, 1H), 1.14 (s, 6H), 1.13 (s, 6H); 13C NMR (101 MHz,
CDCl3): δ 180.47, 140.30, 128.47, 127.82, 127.13, 83.37, 46.79, 24.61, 24.50, 15.81;

11

B NMR

(128 MHz, CDCl3): δ 33.63 (br s).The 13C NMR resonance at 15.81 (methylene carbon signal) has
very low intensity due to 11B quadrupolar broadening

3-boronic acid pinacol ester-2-(4-tertbuylphenyl) propionic acid 2b. white
solid, yield 76% 1H NMR (400 MHz, CDCl3): δ 7.31 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 8.4 Hz, 2H),
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3.83 (dd, J = 9.6, 7.1 Hz, 1H), 1.55 (dd, J = 15.9, 9.6 Hz, 1H), 1.28 (s, 9H), 1.27 (dd, J = 15.8, 7.0
Hz, 1H), 1.14 (s, 6H), 1.11 (s, 6H);

13

C NMR (101 MHz, CDCl3): δ 180.26, 149.96, 137.20,

127.43, 125.37, 83.31, 46.24, 34.38, 31.29, 24.64, 24.46, 15.84; 11B NMR (128 MHz, CDCl3): δ
33.21 (br s). The 13C NMR resonance at 15.84 (methylene carbon signal) has very low intensity
due to 11B quadrupolar broadening

3-boronic acid pinacol ester-2-(4-methylphenyl) propionic acid 2c. white
solid, yield 63% 1H NMR (400 MHz, CDCl3): δ 7.32 (d, J = 8.5 Hz, 2H), 7.01 (d, J = 8.5 Hz, 2H),
3.86 (dd, J = 9.3 Hz, 7.3 Hz, 1H), 2.27 (s, 3H), 1.54 (dd, J = 16.0, 9.3 Hz, 1H), 1.27 (dd, J = 16.1,
7.4 Hz, 1H), 1.14 (s, 6H), 1.13 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 180.21, 137.45, 136.69,
129.14, 127.63, 83.30, 46.36, 24.63, 24.51, 21.00, 16.02; 11B NMR (128 MHz, CDCl3): δ 33.01
(br s).The 13C NMR resonance at 16.02 (methylene carbon signal) has very low intensity due to
11

B quadrupolar broadening

3-boronic acid pinacol ester-2-(4-isobutylphenyl) propionic acid 2d.
white solid, yield 55% 1H NMR (400 MHz, CDCl3): δ 7.20 (d, J = 7.5 Hz, 2H), 7.05 (d, J = 7.5
Hz, 2H), 3.82 (t, J = 8.1 Hz, 1H), 2.42 (d, J = 7.1 Hz, 2H), 1.82 (sept, J = 6.7 Hz, 1H), 1.52 (dd, J
= 15.9, 9.0 Hz, 1H), 1.29 (dd, J = 15.9, 7.5 Hz, 1H), 1.12 (s, 6H), 1.11 (s, 6H), 0.87 (d, J = 6.6 Hz,
6H); 13C NMR (101 MHz, CDCl3): δ 180.73, 140.49, 137.54, 129.16, 127.55, 83.27, 46.44, 45.01,
30.13, 24.60, 24.49, 22.33, 22.30, 15.89;

11

B NMR (128 MHz, CDCl3): δ 33.29 (br s). The

13

C

NMR resonance at 15.89 (methylene carbon signal) has very low intensity due to 11B quadrupolar
broadening
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3-boronic acid pinacol ester-2-(4-methoxyphenyl) propionic acid 2e. white
solid, yield 67% 1H NMR (400 MHz, CDCl3): δ 7.21 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H),
3.80 (dd, J = 9.3, 7.2 Hz, 1H), 3.76 (s, 3H), 1.51 (dd, J = 15.9, 9.2 Hz, 1H), 1.25 (dd, J = 15.9, 7.2
Hz, 1H), 1.14 (s, 6H), 1.13 (s, 6H);

13

C NMR (101 MHz, CDCl3): δ 180.69, 158.63, 132.55,

128.84, 113.84, 83.32, 55.20, 46.00, 24.60, 24.52, 15.99; 11B NMR (128 MHz, CDCl3): δ 33.20
(br s). The 13C NMR resonance at 15.99 (methylene carbon signal) has very low intensity due to
11

B quadrupolar broadening

3-boronic

acid

pinacol

ester-2-(4-N(methyl)acetamide

phenyl)

propionic acid 2f. white solid, yield 64% 1H NMR (400 MHz, CDCl3): δ 7.37 (d, J = 8.3 Hz, 2H),
7.11 (d, J = 8.3 Hz, 2H), 3.89 (t, J = 8.3 Hz, 1H), 3.22 (s, 3H), 1.85 (s, 3H), 1.55 (dd, J = 15.9, 8.7
Hz, 1H), 1.33 (dd, J = 16.0, 8.1 Hz, 1H), 1.14 (s, 12H); 13C NMR (101 MHz, CDCl3): δ 178.83,
170.92, 143.21, 140.39, 129.33, 126.92, 83.30, 46.45, 37.20, 24.58, 24.53, 22.22, 16.02; 11B NMR
(128 MHz, CDCl3): δ 32.66 (br s). The 13C NMR resonance at 16.02 (methylene carbon signal)
has very low intensity due to 11B quadrupolar broadening

3-boronic acid pinacol ester-2-(4-fluorophenyl) propionic acid 2g. white
solid, yield 40% 1H NMR (400 MHz, CDCl3): δ 7.27 (dd, J = 8.6, 5.4 Hz, 2H), 6.97 (t, J = 8.7 Hz,
2H), 3.84 (t, J = 8.3 Hz, 1H), 1.52 (dd, J = 15.9, 8.9 Hz, 1H), 1.30 (dd, J = 15.9, 7.7 Hz, 1H), 1.13
(s, 6H), 1.12 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 180.48, 161.95 (d, J = 245.4 Hz), 135.97 (d,
J = 3.2 Hz), 129.42 (d, J = 8.0 Hz), 115.24 (d, J = 21.4 Hz), 83.43, 46.04, 24.56, 24.50, 15.93; 11B
NMR (128 MHz, CDCl3): δ 33.46 (br s) 19F NMR (376 MHz, CDCl3): δ -115.65 (tt, J = 9.0, 5.4
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Hz). The 13C NMR resonance at 15.93 (methylene carbon signal) has very low intensity due to 11B
quadrupolar broadening

3-boronic acid pinacol ester-2-(3-fluorophenyl) propionic acid 2h. clear oil,
12% 1H NMR (400 MHz, CDCl3): δ 7.28-7.23 (m, 1H), 7.09-7.02 (m, 2H), 6.93 (td, J = 8.5, 2.5
Hz, 1H), 3.86 (t, J = 8.3 Hz, 1H), 1.53 (dd, J = 16.0, 9.1 Hz, 1H), 1.26 (dd, J = 16.0, 7.2 Hz, 1H),
1.15 (s, 6H), 1.14 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 179.68, 162.77 (d, J = 246.0 Hz), 142.70
(d, J = 7.2 Hz), 129.92 (d, J = 8.2 Hz), 123.58 (d, J = 2.9 Hz), 114.95 (d, J = 21.8 Hz), 114.10 (d,
J = 21.1 Hz), 83.51, 46.52, 24.62, 24.54, 15.83; 11B NMR (128 MHz, CDCl3): δ 32.57 (br s); 19F
NMR (376 MHz, CDCl3): δ -113.11 (q, J = 8.6 Hz). The 13C NMR resonance at 15.97 (methylene
carbon signal) has very low intensity due to 11B quadrupolar broadening

3-boronic acid pinacol ester-2-(2-fluorophenyl) propionic acid 2i. clear oil, 6%
1

H NMR (400 MHz, CDCl3): δ 7.30-7.20 (m, 2H), 7.10-7.00 (m, 2H), 4.19 (dd, J = 9.4, 7.0 Hz,

1H), 1.57 (dd, J = 16.0, 9.4 Hz, 1H), 1.25 (dd, J = 16.0, 7.1 Hz, 1H), 1.16 (s, 12H); 13C NMR (101
MHz, CDCl3): δ 179.32, 160.40 (d, J = 246.8 Hz), 129.18 (d, J = 3.9 Hz), 128.69 (d, J = 8.2 Hz),
127.84 (d, J = 14.9 Hz), 124.15 (d, J = 3.5 Hz), 115.43 (d, J = 22.3 Hz), 83.43, 40.01, 24.64, 24.55,
15.02; 11B NMR (128 MHz, CDCl3): δ 33.46 (br s); 19F NMR (376 MHz, CDCl3): δ -117.32 (dt,
J = 11.6, 6.0 Hz). The

13

C NMR resonance at 15.02 (methylene carbon signal) has very low

intensity due to 11B quadrupolar broadening.
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3-boronic acid pinacol ester-2-(6-methoxynaphthalene) propionic
acid 2j. white solid, yield 62% 1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 8.8, 2.2 Hz, 3H), 7.31
(dd, J = 8.5, 1.8 Hz, 1H), 7.02 (dd, J = 8.9, 2.5 Hz, 1H), 6.99 (d, J = 2.5 Hz, 1H), 3.91 (dd, J = 9.1,
7.3 Hz, 1H), 3.80 (s, 3H), 1.55 (dd, J = 16.0, 9.1 Hz, 1H), 1.28 (dd, J = 16.0, 7.3 Hz, 1H), 1.03 (s,
6H), 1.01 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 180.66, 157.53, 135.52, 133.69, 129.27, 128.83,
127.04, 126.46, 126.39, 118.81, 105.55, 83.38, 55.24, 46.75, 24.60, 24.53, 15.96 11B NMR (128
MHz, CDCl3): δ 33.79 (br s). The 13C NMR resonance at 15.96 (methylene carbon signal) has very
low intensity due to 11B quadrupolar broadening

3-boronic acid pinacol ester-2-(3-phenoxyphenyl) propionic acid 2k. clear
oil, yield 58% 1H NMR (400 MHz, CDCl3): δ 7.31 (dd, J = 8.6, 7.4 Hz, 2H), 7.24 (t, J = 7.9 Hz,
1H), 7.10-7.03 (m, 2H), 7.00-6.98 (m, 3H), 6.86 (ddd, J = 8.2, 2.4, 0.9 Hz, 1H), 3.83 (dd, J = 9.3,
7.1 Hz, 1H), 1.53 (dd, J = 16.0, 9.4 Hz, 1H), 1.26 (dd, J = 16.0, 7.1 Hz, 1H), 1.16 (s, 6H), 1.14 (s,
6H);

13

C NMR (101 MHz, CDCl3): δ 180.32, 157.29, 156.97, 142.35, 129.71, 123.27, 122.59,

118.90, 118.46, 117.39, 83.45, 46.75, 24.66, 24.53, 15.90 11B NMR (128 MHz, CDCl3): δ 33.55
(br s). The 13C NMR resonance at 15.90 (methylene carbon signal) has very low intensity due to
11

B quadrupolar broadening; HRMS (ESI) m/z calc. for C21H24BO5- [M-H]- 367.17168, found

367.17152
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3-boronic acid pinacol ester-2-(3-fluorobiphenyl) propionic acid 2l.
white solid, yield 22% 1H NMR (400 MHz, CDCl3): δ 7.51 (d, J = 7.8 Hz, 2H), 7.44-7.35 (m, 4H),
7.17-7.12 (m, 2H), 3.91 (t, J = 8.2 Hz, 1H), 1.58 (dd, J = 16.0, 9.2 Hz, 1H), 1.32 (dd, J = 16.0, 7.3
Hz, 1H), 1.16 (s, 6H), 1.15 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 180.08, 160.78, 158.31, 141.63
(d, J = 7.8 Hz), 135.50, 130.70, 128.92, 128.39, 127.93, 127.79, 127.60, 123.85, 115.63 (d, J =
23.7 Hz), 83.55, 46.33, 24.63, 24.53, 16.00 11B NMR (128 MHz, CDCl3): δ 33.02 (br s) 19F NMR
(376 MHz, CDCl3): δ -117.76 (t, J = 9.8 Hz). The 13C NMR resonance at 16.00 (methylene carbon
signal) has very low intensity due to

11

B quadrupolar broadening; HRMS (ESI) m/z calc. for

C21H23BFO4- [M-H]- 369.16679, found 369.16695

3-boronic acid pinacol ester-2-(4-trifluoromethylphenyl) propionic acid
2m. white solid, yield 18% 1H NMR (400 MHz, CDCl3): δ 7.56 (d, J = 7.9 Hz, 2H), 7.43 (d, J =
7.9 Hz, 2H), 3.93 (t, J = 8.0 Hz, 1H), 1.56 (dd, J = 15.9, 9.1 Hz, 1H), 1.29 (dd, J = 15.9, 7.5 Hz,
1H), 1.13 (s, 6H), 1.13 (s, 6H);

13

C NMR (101 MHz, CDCl3): δ 179.65, 144.29, 129.47 (q, J =

32.3 Hz), 128.29, 125.42, 124.05 (q, J = 272.7 Hz), 83.52, 46.75, 24.55, 24.47, 15.87; 11B NMR
(128 MHz, CDCl3): δ 33.04 (br s)

19

F NMR (376 MHz, CDCl3): δ -62.61 (s). The

resonance at 15.87 (methylene carbon signal) has very low intensity due to

11

13

C NMR

B quadrupolar

broadening; HRMS (ESI) m/z calc. for C16H19BF3O4- [M-H]- 343.13230, found 343.13226

3-boronic acid pinacol ester-2-(4-cyanophenyl) propionic acid 2n. white
solid, yield 39% 1H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 7.7 Hz, 2H), 7.42 (d, J = 7.7 Hz, 2H),
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3.92 (t, J = 8.2 Hz, 1H), 1.55 (dd, J = 16.1, 8.7 Hz, 1H), 1.30 (dd, J = 16.1, 7.8 Hz, 1H), 1.13 (s,
12H);

13

C NMR (101 MHz, CDCl3): δ 178.77, 145.62, 132.27, 128.81, 118.63, 111.10, 83.61,

47.04, 24.56, 24.52, 15.58 11B NMR (128 MHz, CDCl3): δ 33.22 (br s). The 13C NMR resonance
at 15.58 (methylene carbon signal) has very low intensity due to

11

B quadrupolar broadening;

HRMS (ESI) m/z calc. for C16H19BNO4- [M-H]- 300.14071, found 300.14047

3-boronic acid pinacol ester-2-(4-acetoxyphenyl) propionic acid 2o.
white solid, yield 17% 1H NMR (400 MHz, CDCl3): δ 7.31 (d, J = 8.0 Hz, 2H), 7.00 (d, J = 7.8
Hz, 2H), 3.85 (t, J = 8.1 Hz, 1H), 2.27 (s, 3H), 1.53 (dd, J = 16.0, 9.3 Hz, 1H), 1.27 (dd, J = 16.0,
7.2 Hz, 1H), 1.14 (s, 6H), 1.13 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 179.87, 169.39, 149.69,
137.89, 128.89, 121.49, 83.40, 46.22, 24.61, 24.52, 21.09, 16.02; 11B NMR (128 MHz, CDCl3): δ
33.14 (br s). The 13C NMR resonance at 16.02 (methylene carbon signal) has very low intensity
due to

11

B quadrupolar broadening; HRMS (ESI) m/z calc. for C17H22BO6- [M-H]- 333.15094,

found 333.15070

3-boronic acid pinacol ester-2-naphthyl propionic acid 2t. white solid,
yield 65% 1H NMR (400 MHz, CDCl3): δ 7.81-7.77 (m, 4H), 7.47-7.44 (m, 3H), 4.06 (dd, J =
9.4, 7.2 Hz, 1H), 1.67 (dd, J = 16.0, 9.4 Hz, 1H), 1.39 (dd, J = 16.0, 7.2 Hz, 1H), 1.13 (s, 6H), 1.12
(s, 6H); 13C NMR (101 MHz, CDCl3): 180.57, 137.83, 133.34, 132.57, 128.19, 127.77, 127.53,
126.56, 125.98, 125.94, 125.69, 83.40, 46.95, 24.59, 24.51, 15.94; 11B NMR (128 MHz, CDCl3):
δ 33.01 (br s). The 13C NMR resonance at 15.94 (methylene carbon signal) has very low intensity
due to 11B quadrupolar broadening
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Chapter 3: Selective Deboronofluorination of Boracarboxylated Products

3.1 Introduction
Based on our previous success of achieving boracarboxylation for a number of substrates,
our next goal was to explore the synthetic utility of these compounds. One specific transformation
that our group was interested in studying was the conversion of a carbon-boron bond to a carbonfluorine bond. One of the major reasons for the increasing interest of adding fluorine to an organic
compound is derived from the unique properties that can be afforded in pharmaceuticals. Addition
of fluorine to pharmaceutical targets can influence membrane permeability, potency,
conformational changes, and pharmacokinetic properties.63 The influence that fluorination has on
acidity, hydrogen-bonding, and lipophilicity affects the absorption and distribution, making it a
very interesting and important moiety to biological activity.64
One major success has been in the development of fluorine-containing drugs used to treat
disorders of the central nervous system.65 The antidepressant fluoxetine (Eli Lilly), more
commonly known as Prozac, is one of the world’s top 20 best-selling pharmaceuticals and achieves
annual sales of one billion dollars in the United States.66 It has been shown that depression is linked
to low levels of serotonin and that the inclusion of the fluorine functionality in Prozac can increase
the potency for inhibiting serotonin uptake by 6-fold (Figure 3.1).67 Paroxetine (Paxil) is another
treatment for depression which exhibits similar activity to Prozac but with a shorter duration of
action.63 Other major fluorine-containing pharmaceuticals on the market are a cholesterollowering medication (Lipitor), nonsteroidal anti-inflammatory drug (Celebrex), and a treatment
for type 2 diabetes (Januvia), all shown in Figure 3.1.68 It is interesting to note that 20% of all
pharmaceuticals and 30% of agrochemicals contain at least one fluorine atom.69 Despite the
abundance of fluorinated pharmaceuticals, the presence of an aliphatic fluorine is not as prevalent
potentially due to the lack of methods to access these species. The first topical steroid for
inflammation and pain associated with ocular surgery, difluprednate, contains two aliphatic
fluorine moieties (Figure 3.1).70
The carbon-fluorine bond has also shown to have an integral role in tracers for positron
emission tomography (PET). Some examples of fluorine-18 labeled PET imaging probes are
[18F]6-fluoro-L-DOPA, which is a PET ligand for probing cerebral dopamine metabolism and
neuroendocrine tumors in humans, and [18F]FDG for studying glucose metabolism (Figure 3.2).
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radiopharmaceutical.71 The prevalence of fluorine in this field is another motivation for the
synthetic community to be able to effectively introduce a fluorine atom into an organic molecule.

Figure 3.1 Structures of important fluorine-containing pharmaceuticals

Figure 3.2 Structures of fluorine-containing PET tracers
Despite that fluorine’s high electronegativity and small size can provide strong polar
interactions in organic molecules, these properties also result in difficulties with carbon-fluorine
bond formation.72 Based on its ability to form strong hydrogen bonds, fluorine is weakly
nucleophilic in the presence of hydrogen-bond donors, which limits access to C-F bond formation
via conventional nucleophilic substitution reactions. The Balz-Schiemann reaction is a traditional
route to access aryl fluorides from anilines via the thermal decomposition of aryl diazonium
tetrafluoroborate salts (Scheme 3.1).73 Published in 1927, it is the earliest example of the BF4- ion
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as a nucleophilic fluoride source.74 Another traditional route is the Halex process, which involves
the conversion of halogens to fluorine atoms. The first report in 1936 demonstrated the conversion
of 2,4-dinitrochlorobenzene to 2,4-dinitrofluorobenzene, commonly known as Sanger’s reagent
(Scheme 3.2).75 Sanger’s reagent is used for the labeling of peptides and terminal amino acid
groups in proteins, which has promoted this SN2 pathway to be routinely used on an industrial
scale to synthesize a range of similar derivatives.76 Although versatile, the Balz-Schiemann and
Halex reactions require high temperatures and highly reactive intermediates that limit substrate
scope and feasibility. In an effort to develop new ways to selectively introduce fluorine into
organic molecules, electrophilic fluorination has proven to be a viable route. The development of
N-fluorobis(phenyl)sulfonamide (NFSI), N-fluoropyridium salts, and 1-chloromethyl-4-fluoro1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (Selectfluor) provided bench-stable
fluorination reagents that could be used to achieve selective reactivity (Figure 3.3).77

Scheme 3.1 Balz-Schiemann reaction

Scheme 3.2 Halex reaction

Figure 3.3 Structures of some common electrophilic fluorinating reagents
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Due to its fluorination performance and ease of handling, Selectfluor has become a
prominent electrophilic fluorination reagent for many applications since its discovery in the
1990s.78, 79 Through the use of Selectfluor, there have been a number of processes that investigate
the transformation of the carbon-boron bond to a carbon-fluorine bond. One example by the Ritter
group is a silver-mediated fluorination process involving the use of aryl and alkenyl boronic acids,
along with the commercially available and versatile Selectfluor reagent, to achieve fluorinated
aromatic compounds.80 When boronic acids are treated with NaOH in methanol, followed by
AgOTf, an aryl silver intermediate was formed and isolated from this transmetalation step.
Subsequent fluorination was then achieved with the use of Selectfluor (Scheme 3.3). Another
methodology involves the electrophilic fluorination of alkenyl boronic acids and
trifluoroborates.81 Because the fluorination of alkenyl boronic acids was deemed slow, the acid
was transformed to the trifluoroborate salt and then reacted with Selectfluor to form the
corresponding fluorinated alkenes (Scheme 3.4). This reaction has been described as synthetically
appealing due to the use of mild conditions, relatively cheap and non-toxic reagents, and can be
performed in acetonitrile or water.

Scheme 3.3 Ritter’s silver-mediated fluorination of boronic acids

Scheme 3.4 Fluorination of alkenyl boronic acids and trifluoroborates

Although there has been extensive progress in the fluorination of aromatic and alkenyl
organoboron compounds, it seems that aliphatic fluorination techniques have been less explored.
In one report, Lemaire and co-workers developed a strategy to achieve metal-free electrophilic
fluorination of aryl trifluoroborates and boronic acids in which they demonstrate one example of
fluorination of an alkyl trifluoroborate.82 Fluorination was achieved at the benzylic position in a
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75% isolated yield when starting from 1-phenylethyltrifluoroborate (Scheme 3.5). A few years
later, Aggarwal demonstrated the ability to convert chiral boronic esters into alkylfluorides.83 The
starting boronic ester was transformed into a boronate intermediate using PhLi as a nucleophile.
Using styrene as a radial trap, Selectfluor II was used as the electrophilic fluorinating agent to
afford alkylfluoride products with high enantiospecificity (Scheme 3.6).

Scheme 3.5 Metal-free electrophilic fluorination of alkyl trifluoroborates

Scheme 3.6 Aggarwal’s fluorination of boronate esters

Another method developed for the fluorination of alkylboronates demonstrated the ability
to achieve a silver-catalyzed site-specific fluorination pathway.84 Primary, secondary, and tertiary
alkylboronates reacted with Selectfluor in an acidic aqueous solution afforded alkyl fluorides
(Scheme 3.7).

Very interestingly, the Li group reported a similar methodology for a

decarboxylative fluorination pathway just a few years earlier.85 Using Selectfluor as the fluorine
source and AgNO3 as the catalyst, carboxylic acids underwent decarboxylative fluorination in
aqueous solution to afford site-specific fluorination (Scheme 3.8).

Scheme 3.7 Li’s silver-catalyzed fluorination of alkylboronates
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Scheme 3.8 Li’s silver-catalyzed decarboxylative fluorination

3.2 Results
3.2.1 Optimization for deboronofluorination of boracarboxylated products
Initial efforts to fluorinate our boracarboxylated products involved subjecting the
compounds to the Aggarwal fluorination conditions discussed above. The Aggarwal methodology
utilizes boronate complexes to achieve fluorination so we choose to use our synthesized
difluoroboralactone species as a more nucleophilic boron reagent. The para-methyl
difluoroboralactone, 8c, was reacted with Selectfluor in the presence of styrene in acetonitrile
(Scheme 3.9). The reaction was then treated with NaOH and H2O2 in order to oxidize any leftover
boron species. Instead of achieving the desired fluorinated product, 5c, the boron was just oxidized
to an alcohol to form the tropic acid derivative. Using more harsh conditions, the reaction was
performed at an elevated temperature of 40°C and resulted in similar reactivity.

Scheme 3.9 Difluoroboralactone species subjected to Aggarwal fluorination conditions

55

Scheme 3.10 Boracarboxylated products subjected to Li fluorination conditions

Based on the two methodologies by the Li group discussed above, the Popp group wanted
to examine the chemoselectivity achieved when subjecting the boracarboxylated products to
fluorination conditions (Scheme 3.10). We were interested due to the presence of both the
carboxylic acid and boron moiety in these compounds. Both processes by Li utilize AgNO3 as the
catalyst and Selectfluor as the electrophilic fluorination source. The only difference is that the
decarboxylative fluorination occurs in neutral aqueous media while deboronofluorination occurs
in acidic aqueous solution. While screening with Li’s deboronofluorination conditions, we choose
to use the tert-butyl boracarboxylated product due to its high yield, ease of purification, and ability
to synthesize on a multi-gram scale. This model substrate was subjected to a silver catalyst,
Selectfluor as the electrophilic fluorine source, and a biphasic solvent system made up of CH2Cl2,
H2O, and H3PO4. The reaction is refluxed to yield a chemoselective deboronofluorination product,
5b, as well as a difluorination product, 6b, resulting from a deborono- and decarboxylative process.
It is important to note that the decarboxylative monofluorination with Bpin still present is not an
observed by-product of the reaction (Table 3.1).
Similarly to the Li conditions, various silver salts with the addition of trifluoroacetic acid
were examined (entries 1-5, Table 3.1). These are all soluble silver (I) salts that we believed could
act as an active catalyst. The use of AgBF4 without an increase in yield shows that the BF4- ion is
not responsible for any decomposition to a nucleophilic fluoride source (entry 2, Table 3.1). To
our delight, the absence of trifluoroacetic acid increased the yield of our desired
deboronofluorination product. Without the TFA additive, some additional silver salt screening
showed that AgNO3 is the optimal catalyst for this transformation (entries 6-10, Table 3.1).
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Table 3.1 Screening of silver catalysts for deboronofluorinationa

Based on the unexpected increased yields obtained from removing trifluoroacetic acid as
an additive, we wanted to test if just a catalytic amount of TFA would be useful in this
transformation (entry 1, Table 3.2). There seemed to be no change in the yield of 5b so TFA was
completely omitted from all future screening and substrate scope investigation. While screening
solvent ratios, the absence of H3PO4 resulted in a lower yield of 5b product and a much higher
yield of 6b (entry 2, Table 3.2). This result is consistent with a non-acidic solvent condition
observed by Li, which favors a decarboxylative fluorination pathway. However, when the volume
of H3PO4 was doubled, the yield of 5b was slightly decreased (entry 3, Table 3.2) so there seems
to be an optimal intermediate amount of acid that is necessary for reactivity. The lowering of
AgNO3 loading to 10 mol% actually resulted in a similar yield of product distribution; however,
reaction yields dropped off when lowered to only 5 mol% (entries 4 and 5, Table 3.2). It is also
observed that the yield of 5b significantly decreases when attempting to decrease the Selectfluor
from 3 to 1.5 equivalents (entry 6, Table 3.2). When performing the reaction under air, the yield
of 5b was significantly diminished (entry 7, Table 3.2). This can be attributed to the detriment of
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having an external oxidant other than silver during the reaction. Reducing reaction time to 2 hours
showed no change in reactivity, allowing for reaction times to be significantly shortened (entry 8
Table 3.2). Finally, control experiments were performed in the absence of Selectfluor and AgNO3,
respectively (entries 9-10, Table 3.2). Both control studies resulted in no yield of
monofluorination or difluorination products which signifies the necessity for both Selectfluor and
AgNO3 in order to achieve fluorination.
Table 3.2 Screening of reaction conditions for deboronofluorinationa
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3.2.2 Investigation of substrate scope for deboronofluorination
Table 3.3 Substrate scope for the deboronofluorination of boracarboxylated productsa

With the optimal conditions at hand, we began to investigate the substrate scope of this
fluorination pathway. Electron-neutral and bulky electron-donating groups were tolerated in
moderate to good yields (Table 3.3, 5a, 5b, and 5d). Chemoselectivity was confirmed through Xray crystallography of the tert-butyl substrate (5b), shown in Table 3.3 and Appendix I. We were
pleased to be able to obtain the novel NSAID fluoro-ibuprofen in a moderate yield (5d). At present,
there is only one other synthetic route to access β-fluoro-ibuprofen. This reported method utilizes
an iridium catalyst bearing a phosphoamidite ligand to achieve the regioselective and
enantioselective allylic alkylation of fluorobis(phenylsulfonyl)methane.86 The sulfonyl functional
groups are removed by treatment with magnesium in methanol followed by subsequent rutheniumcatalyzed oxidation (Scheme 3.11). This patented method outlines that these NSAID derivatives
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can have some interesting medicinal chemistry applications. Based on the chemoselectivity that is
observed in our catalytic systems, we sought to access this same fluoro-NSAID from a more direct
pathway of boracarboxylation and subsequent fluorination of the para-isobutylstyrene. We believe
that is an attractive synthesis because it reduces the number of steps to the desired target and moves
away from the use of precious metals of iridium and ruthenium.

Scheme 3.11 Synthesis of fluorinated ibuprofen (using iridium and ruthenium)

With knowledge of electron-donating substituents achieving chemoselective fluorination
reactivity, we sought to subject the para-methyl boracarboxylation product to our conditions. The
low yield of 21% for the para-methyl substrate (5c) did not reflect the same pattern of reactivity
seen with other electron-donating substrates. While screening alternative conditions to optimize
reactivity for this substrate, we discovered two other by-products (6c and 7c) that were being
formed in relatively equal amounts to our desired deboronofluorination product, shown in Figure
3.4. Time course data revealed that the fluorination of boracarboxylated para-methylstyrene
yielded a majority of deboronofluorination product with smaller amounts of the two major byproducts early in the reaction. As the reaction time increases, the deboronofluorination product is
consumed by either decarboxylative fluorination or fluorination on the methyl substituent to
produce two distinct difluorinated compounds. For this reason, the para-methyl substrate was only
reacted one hour in the substrate scope (Table 3.3) before other reactivity was initiated.
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Figure 3.4 Time course for p-Me substrate fluorination

Based on the observation of the two other by-products for the fluorination of the p-methyl
substrate, we sought to investigate the optimization of this substrate further (Table 3.4). The
boracarboxylated products can be transformed into a difluoroboralactone species by the use of
KHF2 in 1:1 THF/water. We hypothesized that this difluoroboralactonate salt could be a more
nucleophilic source due to the tetra-coordinate boron center. When subjecting the p-Me
difluoroboralactone species to our fluorination conditions, there was no improvement in yield
(Table 3.4, entry 1). We also tried addition of TFA; however, no increase in yield of 5c was
observed (Table 3.4, entry 2). We attempted to use more harsh conditions by increasing to 80°C
and 100°C in dichloroethane but this did not seem to have any effect on reactivity (Table 3.4,
entries 3-4). The last series of experiments that we screened was varying the amount of phosphoric
acid. When H3PO4 was omitted from the reaction, there was a significant shift in reactivity to form
more of product 6c (Table 3.4, entry 5). This makes sense because in the absence of acid, these
conditions more resemble a neutral aqueous solution in which decarboxylative fluorination is
favorable. The addition of three or even ten times the amount of H3PO4 did not have a dramatic
effect on reactivity (Table 3.4, entries 6-7). Based on these observations, 2c was run at a shorter
reaction time of 1 hour in order to prevent further reactivity to produce 6c and 7c; however, no
other optimization could be achieved to obtain a higher yield.
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Table 3.4 Further screening to attempt to improve p-Me substrate fluorination

The use of slightly electron-deficient substrates seemed to reduce reactivity, as seen by the
para-fluoro (5g), flurbiprofen (5l), and biphenyl (5u) derivatives (Table 3.3). These substrates
exhibited relatively low yields of about 20-30% before isolation. Based on NMR analysis, other
major products of these three substrates include a relatively high yield of difluorinated species,
arising from decarboxylative fluorination and deboronofluorination, which is a common byproduct of all substrates shown above. Other major by-products for these substrates are the formal
hydrocarboxylation product, which arises from a protodeboration pathway, as well as other
fluorinated aromatic products arising from electrophilic aromatic substitution reactivity. To show
an example of this observed reactivity, the 19F NMR spectrum of the crude reaction mixture for
the fluorination of the boracarboxylated flurbiprofen substrate is shown in Figure 3.5. In the region
of -116.5 to -119.5 ppm, the spectrum shows a large number (~7) of fluorinated aromatic species
arising from electrophilic aromatic substitution.
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Figure 3.5 19F NMR spectrum of crude reaction mixture of fluorination of boracarboxylated
flurbiprofen

One other particular substrate of interest to fluorinate was the para-trifluoromethyl
boracarboxylated product because this would provide access to a highly fluorinated compound.
Unfortunately, the electron-withdrawing para-trifluoromethyl fluorination product (5m) showed
minimal reactivity under deboronofluorination conditions (Table 3.5). This transformation also
shows functional group sensitivity. The use of a methoxy substituent (5e and 5j) does not tolerate
the reaction conditions with or without the use of phosphoric acid. The naphthyl substrate (5t) also
showed very minimal yield for deboronofluorination (Table 3.5). Although some substrates show
site selectivity and good yields, we have demonstrated other substrates suffer due to electronics or
functional group tolerance. With these substrates, there was still starting material left over along
with other many minimal by-products (<10%) from electrophilic aromatic substitution chemistry.
In these cases, there was no product isolation due to low yields and undesirable by-products.
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Table 3.5 Unsuccessful substrates for the deboronofluorination of boracarboxylated productsa

3.2.3 Reactivity studies for the fluorination of boracarboxylated products

The reactivity of the tolyl substrate (2c) being fluorinated on the benzyl substituent initially
lead to the idea that this transformation was occurring through a radical pathway. Some initial
experiments to probe this hypothesis involve performing reactions with the addition of radical
traps. As shown in Table 3.6, the yields of all three major products in the fluorination of 2c
diminished in the presence of either of the two radical trapping agents, (2,2,6,6tetramethylpiperidin-1-yl)oxyl (TEMPO) or butylated hydroxytoluene (BHT). The assumption is
that if the pathway does proceed through a radical process, the presence of these stable radicals
will slow or stop reactivity. Although there is a possibility of the reaction not being tolerant to
TEMPO or BHT, it is good initial evidence that this pathway does involve radicals based on the
diminished yields of 5c, 6c, and 7c compared to the control experiment (Table 3.6).
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Table 3.6 Deboronofluorination of tolyl boracarboxylated product in the presence of radical trap
reagentsa

Another area of reactivity that was investigated was the ability to apply Li’s
decarboxylative fluorination conditions to our boracarboxylated products. Revisiting the
deboronofluorination screening, we observed that in the absence of H3PO4 there was a lower
amount of deboronofluorinated product (51%) with a much higher amount of difluorinated product
(18%), which suggests that decarboxylative fluorination is favorable in non-acidic conditions
(Scheme 3.12). Based on this observation, 2b was subjected to Li’s decarboxylative fluorination
conditions. To our surprise, when reacted in the presence of AgNO3 and Selectfluor in an
acetone/water media, 2b yielded minimal amounts of 5b (7%) and 6b (5%) products. Again, there
was no evidence of a decarboxylative fluorination in which the Bpin was still intact (Scheme 3.12).
Finally, when the isolated deboronofluorination product, 5b, was subjected to subsequent
decarboxylative fluorination conditions, the difluorinated product was produced in a moderate
yield of 46% (Scheme 3.12). This series of experiments suggest that the deboronofluorination
pathway seems to be the predominant pathway and then some of this product can undergo
decarboxylative fluorination to afford the difluorinated product.
The difluorination of vinyl arenes is a transformation that has been known since 1966 when
Merritt and co-workers subjected cis-stilbene to F2 in order to achieve 1,2-difluoro-1,2diphenylethane.87 A similar methodology reacted trans-stilbene with a combination of Selectfluor
and HF·pyridine to achieve the same difluorinated product.88 The 1,2-difluorination of alkenes has
also recently received a lot of attention by the Jacobsen group, in which their catalytic approach
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utilized a nucleophilic fluoride source (HF·pyridine) and an oxidant (mCPBA) in conjunction with
an aryl iodide catalyst to access diasteroselective difluorinated vinyl arenes.89, 90

Scheme 3.12 Investigation of the decarboxylative fluorination process

3.2.4 Mechanistic investigation for the fluorination of boracarboxylated products
Because of our substrate scope limitations, we sought to investigate the mechanism further
than the reactivity studies discussed above. One plausible route would involve a SE2 pathway,
resulting in the inversion of stereochemistry of an enantiopure starting material, similar to the
methodology by Aggarwal (Figure 3.6). Another pathway would involve a single electron
oxidation of the alkylboronate by a Ag(III)-F to yield an alkyl radical, which was previously
proposed by the Li group. If starting with a specific enantiomer, the radical pathway would result
in a racemic mixture of products (Figure 3.6). Because the boracarboxylation reaction is not
performed asymmetrically at this point, another strategy was employed to investigate the
mechanistic pathway. We utilized the trans-β-methyl styrene substrate, which yields a high
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diastereomeric ratio (>7:1) of boracarboxylated products observed in the 1H NMR analysis
(Scheme 3.13 and Figure 3.7). We proposed that if the diastereomeric ratio was maintained after
undergoing fluorination, the mechanism was proceeding through an SE2-type pathway. If the
diastereomeric ratio was diminished after fluorination, this would suggest a radical pathway.

Figure 3.6 Plausible mechanisms for deboronofluorination

Scheme 3.13 Copper-catalyzed boracarboxylation of trans-β-methyl styrene
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Figure 3.7 1H NMR spectrum of boracarboxylation of trans-β-methyl styrene showing the two
diastereomers in a >7:1 ratio

Before the boracarboxylated trans-β-methyl styrene, 1v, was reacted under fluorination
conditions, we first wanted a way to assign the 1H resonances to the corresponding diastereomer.
The boracupration occurs in a syn addition so the syn boracarboxylation arises from a
stereoretentive insertion of carbon dioxide, while the anti boracarboxylation is the result of a
stereoinvertive SE2 pathway. Because of the free rotation of the single bonds in the
boracarboxylated products, we used KHF2 to form the two difluoroboralactone species and lock
all of the atoms into place in the five-membered boralactone ring. The syn diastereomer, 2v, would
result in the trans-boralactone, 8v, and the anti diastereomer, 2v’, resulted in the cis-boralactone,
8v’ (Scheme 3.14).
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Scheme 3.14 Conversion of the trans-β-methyl boracarboxylated diastereomers to the
difluoroboralactone species

In order to elucidate the stereochemistry, we first sought to use the 3J coupling constants
between the two methine protons in the boralactone. In the 1H NMR of the difluoroboralactones,
one benzylic proton resonance at 3.80 ppm showed a 3JH-H coupling constant of 8.5 Hz (Figure
3.8), which would seem to be consistent with a trans relationship between the two methine protons.
Upon further analysis, the benzylic proton resonance at 3.04 ppm corresponding to the other
diastereomer showed an even higher 3JH-H coupling constant of 9.7 Hz (Figure 3.8). Based on the
Karplus correlation, these types of 5-membered rings can exhibit relatively large couplings for
vicinal cis protons as well as trans protons because they have small dihedral angles.91 Based on
the large coupling constants of both benzylic protons, we were not able to use this data to match
the resonances to the two diastereomers. This resulted in the use of 2D NOESY spectra to
determine through-space correlations. The benzylic proton at 3.04 ppm (labeled as H1 in Figure
3.9) showed a correlation in the NOESY spectrum to the ortho-proton of the aromatic ring and to
the protons of the CH3. Based on these correlations, we can assign the benzylic proton at 3.04 ppm
to the trans-boralactone, 8v. The cis-boralactone, 8v’, is assigned to the benzylic proton at 3.80
ppm, confirmed by the correlation in the NOESY spectrum between H1 and H2 (labeled in Figure
3.10). Because more of the trans-boralactone is formed in a 16:1 ratio (Figure 3.8), we can make
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the assumption that more syn boracarboxylated product is formed. Based on this analysis, we know
that the syn:anti ratio in the boracarboxylation of trans-β-methyl styrene is >7:1.

Figure 3.8 1H NMR spectrum of the two diastereomers of the trans-β-methyl difluoroboralactones
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Figure 3.9 Expanded portion of the 2D NOESY spectrum for the trans-boralactone
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Figure 3.10 Expanded portion of the 2D NOESY spectrum for the cis-boralactone

In order to determine the mechanistic pathway, the boracarboxylated trans-β-methyl
diastereomers, 2v-2v’, were subjected to the typical deboronofluorination conditions (Scheme
3.15). Fluorination was achieved as shown by Figure 3.11, in which the

19

F NMR shows two

distinct fluorine resonances in a doublet of quartet of doublets (dqd) splitting pattern. This splitting
arises from the fluorine coupling to the geminal proton, the three methyl protons, and the vicinal
proton, respectively. The 19F NMR integrations show that these two diastereomers are formed in
a <2:1 ratio (Scheme 3.15 and Figure 3.11). The diminished diastereomeric ratio suggests a radical
pathway for the deboronofluoriantion of boracarboxylated products. This also helps to confirm
some of the reactivity observed previously with the fluorination of the methyl substituent in the
para-methyl substrate and the diminished reactivity observed when using radical trapping agents
such as TEMPO or BHT.
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Scheme 3.15 Fluorination of trans-β-methyl styrene boracarboxylated diastereomers

A
B

Figure 3.11 19F NMR spectrum for the fluorination of trans-β-methyl styrene boracarboxylated
diastereomers
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Although the ratio of the diastereomers was important for gaining mechanistic insight, we
also wanted to assign the fluorine resonances to the corresponding fluorination product. In order
to determine which resonance corresponded to the syn or anti diastereomer, we used the

19

F-13C

heteronuclear multiple bond correlation (HMBC) spectra, which shows the 2JFC and 3JFC coupling
constants. Both fluorine resonances exhibit cross-peaks to the adjacent benzylic carbon and the
carbon of the methyl group at 58 ppm and 19 ppm, respectively (Figure 3.12). The fluorine
resonance (A) at -171.3 ppm exhibits another cross-peak around 133 ppm, which is the coupling
to ipso carbon of the phenyl ring. The absence of a cross-peak around 175 ppm indicates a
relatively small coupling constant (<3 Hz) to the carboxylic acid. This signifies that the fluorine
and carboxylic acid are in close proximity or in the syn conformation. This means that the fluorine
resonance A corresponds to the syn diastereomer, which is formed in a slightly higher amount
based on integrations (Figure 3.11).
This is further confirmed by the examining the peak at -179.8 ppm (B). In the

19

F-13C

HMBC, the resonance shows a cross-peak with the carboxylic acid region of around 175 ppm. The
presence of the cross-peak indicates that the coupling constant is relatively large so this
diastereomer shows an anti-relationship between the carboxylic acid and fluorine. Further, the
absence of a cross-peak for the fluorine and ipso carbon of the phenyl means the coupling constant
is small due to close proximity. The shifts can also be explained based on the anisotropic effect.
When the phenyl ring is placed in a magnetic field, the π electrons are induced to circulate, causing
an anisotropic magnetic field. In the anti diastereomer, the fluorine is in close proximity to the
phenyl ring and is shielded, causing the more upfield signal in the 19F NMR spectrum.

74

19F

13C

Figure 3.12 19F-13C HMBC from the fluorination of boracarboxylated trans-β-methyl styrene
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3.3 Conclusion
In this chapter, we have outlined a methodology to achieve the chemoselective
deboronofluorination of some boracarboxylated products. Taking advantage of boracarboxylation
and subsequent fluorination, we have a direct, efficient synthesis of the β-fluoro-ibuprofen NSAID
derivative. Although chemoselective for some substrates, this method suffers in functional group
compatibility due to other reactivity pathways such as electrophilic aromatic substitution. Based
on the reactivity that was observed, these limitations were investigated by probing the mechanism.
Using a substrate with stereochemical information, we observed diminished diastereomeric ratios
when subjected to fluorination conditions, suggesting a radical pathway is occurring in this
transformation.

3.4 Experimental Methods
3.4.1 General information
Dichloromethane and 85% phosphoric acid were purchased from Fisher and the water was
used from the DI tap at WVU for the biphasic solvent system. Deuterated CDCl3 was purchased
from Cambridge Isotope Laboratories, Inc. NMR spectra were recorded on either a 400 MHz
Agilent or a 400 MHz JEOL NMR spectrometer. 1H NMR experiments were run in CDCl3 using
tetramethylsilane as an internal standard and

13

C NMR spectra used CDCl3 as a solvent and

reference. High-resolution mass spectra were recorded on a Thermo Fisher Scientific Q Exactive
Mass Spectrometer dissolving our samples in 1:1 methanol/acetonitrile. All boracarboxylated
starting materials were synthesized and isolated with <5% impurities of B2pin2 before subjected to
fluorination conditions. The fluorinated compounds were purified by chromatography using
SiliaCycle thin-layer chromatography plates and SiliCycle SiliaFlash P60 silica gel.

3.4.2 Experimental procedures
For all substrate scope reactions, a 20-mL vial was taped with black electrical tape to avoid
any light sensitivity issues. The vial was first charged with a stir bar, boracarboxylated product
(0.2 mmol, 1.0 eq.), AgNO3 (3.4 mg, 0.02 mmol, 10 mol%), and Selectfluor (213 mg, 0.6 mmol,
3 eq.). To the solids, 3.0 mL of dichloromethane, 3.5 mL of deionized water, and 0.1 mL of 85%
phosphoric acid were added to the reaction vial. A septum cap was secured tightly on the vial and
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taped. The septum cap was punctured with a needle to purge the reaction mixture with argon for 5
minutes with an outlet to a bubbler. The puncture was taped over to prevent any evaporation of
solvent. The reactions were stirred at reflux (55°C) for 2 hours. During screening, reactions were
run for 12 hours. In some cases, the reactions were performed with an addition of 0.4 mL of
trifluoroacetic acid, as discussed above in the results. Upon reaction completion, the crude mixture
was allowed to cool to room temperature and added to a separatory funnel. The organic layer was
extracted with dichloromethane (15 mL x 3). The combined organic layers were collected in a 100
mL round-bottom flask and concentrated under vacuum to give the crude product. Fluorobenzene
(0.04 mmol, 20 mol%) was added to the crude mixture as an internal standard and dissolved in
CDCl3 to be analyzed by

19

F and 1H NMR. If fluorinated product was present in a reasonable

amount, the crude product was isolated by column chromatography or thin-layer chromatography.
1

H, 13C and 19F NMR characterization data was carried out on purified compound, along with high-

resolution mass spectroscopy. During the mechanistic investigation of the fluorination pathway,
some 2D NMR techniques such as NOESY were performed to help elucidate the different
diastereomers present.

3.4.3 Characterization of isolated compounds

3-fluoro-2-phenyl propionic acid 5a. Purified by thin-layer chromatography eluting
with 3:2 hexanes/ethyl acetate (Rf ~0.5) to afford a clear oil in 53% yield; 1H NMR (400 MHz,
CDCl3) δ = 7.38-7.25 (m, 5H), 4.93 (dt, J = 46.4, 8.9 Hz, 1H), 4.59 (ddd, J = 46.4, 9.0, 5.2 Hz,
1H), 4.03 (ddd, J = 13.8, 9.0, 5.1 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ = 177.12, 133.21 (d, J
= 8.4 Hz), 129.03, 128.37, 128.26, 83.29 (d, J = 174.3 Hz), 52.13 (d, J = 19.1 Hz); 19F NMR (376
MHz, CDCl3) δ = -216.63 (td, J = 46.5, 13.7 Hz); HRMS (ESI) m/z calc. for C9H8FO2- [M-H]167.0508, found 167.0505
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3-fluoro-2-(4-tertbutylphenyl) propionic acid 5b. Purified by silica gel flash
chromatography eluting with 3:2 hexanes/ethyl acetate (Rf ~0.5) to afford a white solid in 60%
yield; 1H NMR (400 MHz, CDCl3) δ = 7.37 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 4.94 (dt,
J = 46.5, 9.1 Hz, 1H), 4.58 (ddd, J = 46.5, 9.1, 5.3 Hz, 1H), 4.02 (ddd, J = 13.9, 9.1, 5.2 Hz, 1H),
1.30 (s, 9H); 13C NMR (101 MHz, CDCl3) δ = 176.98, 151.43, 129.82, 127.87, 125.98, 83.26 (d,
J = 174.5 Hz), 51.52 (d, J = 21.2 Hz), 34.53, 31.21; 19F NMR (376 MHz, CDCl3) δ = -216.13 (td,
J = 46.2, 13.3 Hz) HRMS (ESI) m/z calc. for C13H16FO2- [M-H]- 223.1134, found 223.1132

3-fluoro-2-(4-methylphenyl) propionic acid

5c.

Purified by thin-layer

chromatography eluting with 3:2 hexanes/ethyl acetate (Rf ~0.5) to afford a white solid in 21%
yield; 1H NMR (400 MHz, CDCl3) δ = 7.18 (d, J = 8.1 Hz, 2H), 7.14 (d, J = 8.1 Hz, 2H), 4.90 (dt,
J = 46.5, 9.0 Hz, 1H), 4.55 (ddd, J = 46.5, 8.9, 5.5 Hz, 1H), 3.97 (ddd, J = 13.9, 8.8, 5.5 Hz, 1H)
2.32 (s, 3H);

13

C NMR (101 MHz, CDCl3) δ = 177.07, 138.25, 130.10 (d, J = 8.5 Hz), 129.71,

128.09, 83.27 (d, J = 174.4 Hz), 51.65 (d, J = 21.1 Hz) 21.06; 19F NMR (376 MHz, CDCl3) δ =
-216.40 (td, J = 46.5, 13.6 Hz) HRMS (ESI) m/z calc. for C10H10FO2- [M-H]- 181.0659, found
181.0658

3-fluoro-2-(4-isobutylphenyl) propionic acid 5d. Purified by silica gel flash
chromatography eluting with 3:2 hexanes/ethyl acetate (Rf ~0.5) to afford a white solid in 45%
yield; 1H NMR (400 MHz, CDCl3) δ = 7.21 (d, J = 8.0 Hz, 2H), 7.12 (d, J = 7.9 Hz, 2H), 4.93 (dt,
J = 46.5, 9.0 Hz, 1H), 4.57 (ddd, J = 46.4, 9.0, 5.2 Hz, 1H), 4.00 (ddd, J = 13.9, 9.1, 5.3 Hz, 1H),
2.45 (d, J = 7.2 Hz, 2H), 1.89-1.79 (m, 1H), 0.89 (d , J = 6.5 Hz, 6H); 13C NMR (101 MHz, CDCl3)
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δ = 177.07, 141.99, 130.28 (d, J= 8.8 Hz), 129.73, 127.92, 83.35 (d, J = 174.3 Hz), 51.73 (d, J =
20.9 Hz), 44.99, 30.11, 22.32; 19F NMR (376 MHz, CDCl3) δ = -216.08 (td, J = 46.6, 13.6 Hz)
HRMS (ESI) m/z calc. for C13H16FO2- [M-H]- 223.1134, found 223.1122

3-fluoro-2-(4-fluorophenyl) propionic acid

5g.

Purified by thin-layer

chromatography eluting with 4:1 hexanes/ethyl acetate with 4% acetic acid (Rf ~0.5) to afford a
clear oil in 31% yield; 1H NMR (400 MHz, CDCl3) δ = 7.28 (dd, J = 8.4, 5.2 Hz, 2H), 7.03 (t, J =
8.4 Hz, 2H), 4.88 (dt, J = 46.4, 8.8 Hz, 1H), 4.59 (ddd, J = 46.3, 9.0, 5.5 Hz, 1H), 4.00 (ddd, J =
15.8, 8.8, 5.5 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ = 176.78, 162.66 (d, J = 247.6 Hz), 129.98
(d, J = 8.3 Hz), 128.94 (dd, J = 7.9, 3.5 Hz), 116.00 (d, J = 21.7 Hz), 83.12 (d, J = 175.3 Hz), 51.24
(d, J = 21.7 Hz); 19F NMR (376 MHz, CDCl3) δ = -113.41 (ddd, J = 13.7, 8.6, 5.2 Hz), -217.13
(td, J = 46.3, 14.5 Hz) HRMS (ESI) m/z calc. for C9H7F2O2- [M-H]- 185.0420, found 185.0414

3-fluoro-2-(3-fluorobiphenyl) propionic acid 5l. Purified by thin-layer
chromatography eluting with 4:1 hexanes/ethyl acetate with 4% acetic acid (Rf ~0.4) to afford a
white solid in 13% yield; 1H NMR (400 MHz, CDCl3) δ = 7.50 (d, J = 7.3 Hz, 2H), 7.44-7.36 (m,
4H), 7.18-7.14 (m, 2H) 4.94 (dt, J = 46.1, 8.5 Hz, 1H), 4.67 (ddd, J = 46.3, 8.8, 5.5 Hz, 1H), 4.06
(ddd, J = 13.9, 8.0, 5.4 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ = 175.88, 159.70 (d, J = 249.0
Hz), 135.00, 134.38 (d, J = 8.1 Hz), 131.25 (d, J = 3.1 Hz), 129.20 (d, J = 12.8 Hz), 128.90, 128.48,
127.90, 124.36 (d, J = 3.3 Hz), 116.13 (d, J = 24.5 Hz), 83.01 (d, J = 175.2 Hz), 51.45 (d, J = 20.9
Hz);

19

F NMR (376 MHz, CDCl3) δ = -116.66 (t, J = 9.4 Hz), -217.68 (td, J = 46.3, 14.4 Hz)

HRMS (ESI) m/z calc. for C15H11F2O2- [M-H]- 261.0733, found 261.0734
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3-fluoro-2-biphenyl

propionic

acid

5u.

Purified

by

thin-layer

chromatography eluting with 4:1 hexanes/ethyl acetate with 4% acetic acid (Rf ~0.4) to afford a
white solid in 12% yield; 1H NMR (400 MHz, CDCl3) δ = 7.58-7.53 (m, 4H), 7.44-7.38 (m, 4H),
7.34 (t, J = 7.2 Hz, 1H), 4.97 (dt, J = 46.2, 8.6 Hz, 1H), 4.65 (ddd, J = 46.2, 9.0, 5.1 Hz, 1H), 4.08
(ddd, J = 14.1, 8.6, 5.8 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ = 176.38, 141.42, 140.32, 132.10
(d, J = 8.0 Hz), 128.79, 128.67, 127.75, 127.53, 127.07, 83.23 (d, J = 174.8 Hz), 51.65 (d, J = 21.1
Hz); 19F NMR (376 MHz, CDCl3) δ = -216.74 (td, J = 46.4, 13.9 Hz) HRMS (ESI) m/z calc. for
C15H12FO2- [M-H]- 243.0827, found 243.0825
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Chapter 4: Progress in Suzuki Cross-Coupling of Boracarboxylated Products

4.1 Introduction
Another area of synthetic utility that our group wanted to explore was the cross-coupling
of our boracarboxylated products. Similarly to fluorinated compounds, there is a drive to
synthesize 2,3-diarylpropionic acids based on their prevalence as biologically active compounds.
The synthesized compound DX-9065a exhibited potent and highly selective anti-FXa activity as
an anticoagulant bearing both a basic moiety and carboxylic acid functionality (Figure 4.1).92 A
series of 2,3-diphenylpropionic acid derivatives have also shown activity as potent VLA-4
antagonists with good pharmacokinetics and oral bioavailability (Figure 4.1). The integrin very
late antigen-4 is involved in cell adhesion, migration, and activation of leukocytes.93

Figure 4.1 Biologically active 2,3-diarylpropionic acids

There are a number of synthetic routes to access 2,3-diarylpropionic acid derivatives. A
few examples utilizing an alkylation pathway will be described. One method by Miyata
demonstrated that the triethylsilylation of a lithium enolate resulted in the formation of a N,Oketene acetal.94 This could undergo subsequent nucleophilic phenylation with triphenyl aluminum
to afford an α-phenylated product that can readily be converted into the 2,3-diphenyl propionic
acid without racemization by the addition of 4 M HCl (Scheme 4.1). Another strategy employs the
use of a chiral lithium amide to achieve an enantioselective direct alkylation of arylacetic acids.95
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There is also an interesting strategy using Rh2(BPCP)4 that demonstrated the site-selective C-H
insertion of carbenes into toluene derivatives (Scheme 4.1).96

Scheme 4.1 Traditional alkylation approaches to synthesize 2,3-diphenylpropionic acids

One of the major strategies to access these biaryl propionic acid derivatives reported
recently is through a formal hydrocarboxylation of stilbenes. One example, previously discussed
in Chapter 1, involves Skrydstrup’s hydroboration of stilbenes followed by NHC-ligated coppercatalyzed carboxylation. It is important to note that in this strategy stilbenes that have
electronically similar aryl rings exhibit a mixture of both the α- and β-isomers. By employing a
stilbene with an electron-deficient and an electron-rich aryl ring, a single regioisomer could be
achieved, albeit in a lower yield (Scheme 4.2). A hydrocarboxylation strategy by Martin and coworkers revealed a site-selective hydrocarboxylation of a wide range of unsaturated hydrocarbons
using water as the hydride source.97 In this report, there was one example of reactivity of an
unsymmetrical stilbene. A similar selectivity was observed in this case where the carboxylic acid
was installed at the α-position of the electron-deficient aryl ring (Scheme 4.3). The final
hydrocarboxylation approach is a palladium-catalyzed process in the presence of formic acid and
benzoic acid.98 When unsymmetrical stilbenes were investigated, an ortho-substituent was added
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to one of the phenyl groups to create steric differentiation while both regioisomers were formed
(Scheme 4.4).

Scheme 4.2 Skrydstrup’s hydroboration/carboxylation strategy to access 2,3-diarylpropionic
acids

Scheme 4.3 Martin’s catalytic hydrocarboxylation

Scheme 4.4 Shi’s palladium-catalyzed hydrocarboxylation
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Based on these hydrocarboxylation strategies, it seems that the methodologies commonly
employed rely on the electronics or sterics of the aryl rings to determine regioselectivity of the
carboxylic acid. Due to our boracarboxylation protocol, we already set the regiochemistry of the
acid moiety, affording a unique opportunity to perform cross-coupling to achieve these 2,3-diaryl
propionic acids. This Nobel Prize winning reactivity has been established as a versatile and
powerful tool to transform a carbon-boron bond into a carbon-carbon bond. Suzuki cross-coupling
has proven to be a revolutionary reaction since its discovery in 1979.99, 100

Scheme 4.5 Cross-coupling of an alkylboronate ester

Scheme 4.6 Crudden’s orthogonal cross-coupling methodology

We thought this to be a viable route because there are some examples in the literature that
demonstrate β-substituted alkylboronate esters can undergo cross-coupling chemistry. One
example shows the linear hydroboration product of styrene could react with chlorobenzene to
afford the cross-coupling product through the use of a Pd(OAc)2/RuPhos catalyst system (Scheme
4.5).101 A sequential cross-coupling of borylated compounds has also been achieved in order to
couple a β-substituted alkylboronate.102 One example from Crudden’s group demonstrates
orthogonal coupling to generate triarylated compounds of pharmaceutical interest.103 The initial
compound contains three different C-B bonds: B-C(sp2), primary B-C(sp3), and secondary B-C(sp3).
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The first coupling was achieved without loss of either of the aliphatic pinacol boronate groups and
the second coupling reaction left the benzylic B-C bond intact to produce the triarylated product
(Scheme 4.6).
While reviewing the literature, we observed that these benzylic carboxylic acids can be
used as a directing group to achieve C-H functionalization in the ortho position of arenes.104 In
one specific example, Yu and co-workers reported a methodology to achieve a carboxylatedirected palladium-catalyzed C-H olefination (Scheme 4.7).105 Yu also developed another diverse
and high yielding example of the ortho-arylation of enantiomerically pure pivaloyl-protected
mandelic acid derivatives (Scheme 4.8).106 This methodology does not require the installation and
removal of a directing group while achieving monoselectivity. This C-H functionalization also
occurs with no epimerization of the α-chiral centers.

Scheme 4.7 Yu’s ortho-olefination strategy using a carboxylic acid directing group

Scheme 4.8 Yu’s ortho-arylation methodology using a carboxylic acid directing group
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4.2 Results
4.2.1 Optimization for cross-coupling of boracarboxylated products
Based on the reactivity shown in the literature, the Popp group wanted to investigate the
ability to perform cross-coupling chemistry on our boracarboxylated products to achieve access to
2,3-diarylpropionic acids through a new strategy. We were also aware of the possibility of
activating the ortho-position of the phenyl ring due to the directing group nature of the free
carboxylic acid functionality. As in the fluorination project, we investigated the ability to achieve
this catalysis using the tert-butyl boracarboxylated product due to its high yield and ease of
purification. This boracarboxylated product was coupled with 4-bromobenzotrifluoride. We hoped
that the electron-withdrawing nature of the coupling partner would allow for a favorable oxidative
addition of the aryl bromide. During initial catalyst screening, two different palladium (0) sources
without ligand showed minimal reactivity (Table 4.1, entries 1-2). While Pd(PPh3)4 was employed
as a catalyst, the optimal solvent mixture was determined to be THF/water and Cs2CO3 as the
optimal base (Table 4.1, entries 3-4). When attempting to switch to a palladium (II) catalyst,
reactivity was completely shut down (Table 4.1, entry 5). Next, Pd(OAc)2, Pd(PPh3)4, and Pd(dba)2
were all used as palladium sources in the presence of the Buchwald ligand, XPhos (Table 4.1,
entries 6-8). Based on the highest reactivity observed with Pd(dba)2, this source of palladium (0)
was used with the RuPhos ligand to achieve a high yield of the 2,3-diarypropionic acid (Table 4.1,
entry 9).
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Table 4.1 Screening of catalyst conditions for the cross-coupling of boracarboxylated productsa

Table 4.2 Screening of reaction conditions for the cross-coupling of boracarboxylated productsa
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While screening different reaction conditions, we showed that the use of Pd(dba)2 at 10
mol% and RuPhos at 20 mol% could achieve a 95% yield of the cross-coupled product (Table 4.2,
entry 1). When attempting to decrease the loading of base by half from 5 to 2.5 equivalents, the
reaction yield did drop off by at least a 20% yield (Table 4.2, entry 2). When attempting to decrease
the palladium and ligand loading to 5 mol% and 10 mol%, respectively, there was also a significant
decrease in yield (Table 4.2, entry 3). Adding more equivalents of the aryl bromide did not seem
to increase the yield much at the lower catalyst loading (Table 4.2, entries 4-5). At these lower
catalyst loading reaction conditions, there was still starting material present in the NMR so it was
shown that the yield of cross-coupling could be improved by increasing the reaction time to 48
hours (Table 4.2, entry 6). Finally, the Pd(dba)2 and RuPhos were both run at 5 mol% in 48 hours
to show a good yield of product; however, the reaction seems to proceed better with excess ligand
(Table 4.2, entry 7).

Table 4.3 Substrate scope of boracarboxylated products for cross-couplinga
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Figure 4.2 X-ray crystal structure of cross-coupling product, 9a

Using the optimized reaction conditions, we first probed the cross-coupling reactivity of
some of our boracarboxylated products with 4-bromobenzotrifluoride in the presence of the
Pd(dba)2/RuPhos catalyst system. We were pleased to demonstrate good yields of the crosscoupled products to afford a number of 2,3-diarylpropionic acid derivatives (Table 4.3). We
observed that the boracarboxylated product of styrene underwent cross-coupling in a high yield to
access the opposite regioisomer that had previously been shown, in which the carboxylic acid is
now situated at the α-position of the more electron-rich aryl ring (9a). This product with reversed
regioselectivity has been confirmed through crystallographic analysis (Figure 4.2 and Appendix
1). The cross-coupling procedure affords high yields with boracarboxylated products bearing an
electron-donating group in the para-position such as tert-butyl, methyl, isobutyl and methoxy (9b,
9c, 9d, and 9e). Cross-coupling is also achieved with the slightly electron-withdrawing para-fluoro
boracarboxylated product (9g). This method demonstrates the ability to cross-couple to access
substrates with extended π-systems such as fluorbiprofen (9l), naphthyl (9t), and biphenyl (9u).
Reactivity could also be achieved in good yield by utilizing the electron-withdrawing metamethoxy boracarboxylated product (9w).
Next, we wanted to investigate the scope of aryl bromides that would undergo crosscoupling with the tert-butyl boracarboxylated substrate (Table 4.4). The methodology favored the
trifluoromethyl and fluoro para-substituted aryl bromides in good yields (9b-10b); however, the
2,4,6-trifluorobromobenzene resulted in a low yield of the cross-coupled product (11b),
presumably due to the substitution on both ortho positions. Two other para-substituted electronwithdrawing aryl bromides showed reactivity with tolerance of the nitro and cyano functionalities
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(12b-13b). The strongly donating bromoanisole also demonstrated cross-coupling with the tertbutyl boracarboxylated product (14b). Interestingly, we were also able to use bromostyrene as a
coupling in high yield of the coupled product (15b). The alkene functionality allows a point for
further synthetic elaboration of this 2,3-diarylpropionic acid. Finally, para-methyl and orthoxylene aryl bromides showed good tolerance to the reaction conditions allowing for methyl
substituted derivatives (16b-17b).

Table 4.4 Substrate scope of aryl bromides for cross-couplinga

Another group of substrates that were investigated is the scope of heterocycles that could
undergo reactivity (Table 4.5). The 2-bromopyridine showed no reactivity under the optimized
conditions (18b) while the 3- and 4-bromopyridine resulted in low yield (19b-20b). The 2- and 3bromofuran, along with the 2-bromothiophene, showed minimal cross-coupled product as well
(21b-23b). The yields of cross-coupling significantly increased when employing the benzofuran
and benzothiophene variants of the heterocycles. The 5-bromobenzofuran and 590

bromobenzothiophene resulted in good yields of cross-coupling (24b-25b). When the 3bromothiphene was screened, the yield did decrease significantly due to the proximity to the
heteroatom (26b). Finally, we demonstrated moderate yields of cross-coupling between
boracarboxylated tert-butylstyrene and bromo-substituted indoles (27b-28b).

Table 4.5 Substrate scope of heterocycles for cross-couplinga

One more area of investigation was to perform a one-pot boracarboxylation and crosscoupling protocol

(Scheme

4.9).

The

tert-butylstyrene

was

reacted

under

regular

boracarboxylation conditions to install the CO2 and Bpin moiety. After 24 hours, the crosscoupling catalyst solution of Pd(dba)2 and RuPhos was dissolved in THF and was added to the
round-bottom containing the boracarboxylation mixture without any type of workup. The reaction
vessel was flushed with argon and allowed to stir for about 5 minutes before the 4bromobenzotrifluoride coupling partner, base, and water were added. This reaction was allowed
to reflux for an additional 24 hours. After typical reaction workup, the cross-coupled product was
achieved in a moderate yield of 40%. This allows for a protocol in which the boracarboxylated
product does not need to be isolated in order to achieve the 2,3-diarylpropionic acid product.
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Scheme 4.9 One-pot boracarboxylation/cross-coupling

4.3 Conclusion
In this chapter, we have outlined a protocol to derivatize the boron moiety in
boracarboxylated products through the versatile reactivity of cross-coupling. We demonstrate the
ability to use a new methodology to access a number of 2,3-diarylpropionic acid derivatives. Using
our approach, the position of the carboxylic acid is already set through boracarboxylation. This
provides the opposite regioisomer observed when compared to the traditional hydrocarboxylation
strategies that are commonly employed. This chapter shows the ability to access a number of
interesting biaryls products through the use of a variety of different boracarboxylated products,
aryl bromides, and heterocycles. We have also shown the ability to perform a one-pot tandem
boracarboxylation/cross-coupling strategy to achieve desired product formation without workup
of the intermediate boracarboxylated product. More work is still underway to screen additional
substrates and carry out isolation of products.

4.4 Experimental Methods
4.4.1 General information
Dry tetrahydrofuran was used for all experiments from a Glass Contour solvent purification
system and the water was used from the DI tap at WVU for the reaction solvent. Deuterated CDCl3
was purchased from Cambridge Isotope Laboratories, Inc. NMR spectra were recorded on either
a 400 MHz Agilent or a 400 MHz JEOL NMR spectrometer. 1H NMR experiments were run in
CDCl3 using tetramethylsilane as an internal standard and

13

C NMR spectra used CDCl3 as a

solvent and reference. All boracarboxylated starting materials were synthesized and isolated with
<5% impurities of B2pin2 before subjected to cross-coupling conditions. The 2,3-biaryl propionic
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acid compounds can be isolated by slowly cooling a hot hexanes solution or layering
dichloromethane with hexanes in a -20°C freezer.

4.4.2 Experimental procedures
For all substrate scope reactions, a 20-mL vial was first charged with a stir bar, Pd(dba)2
(11.6 mg, 0.02 mmol, 10 mol%), RuPhos (18.6 mg, 0.04 mmol, 20 mol%) and 4.0 mL of THF.
The vial was swirled to ensure all palladium and ligand was dissolved. Next, boracarboxylated
product (0.2 mmol, 1.0 eq), Cs2CO3 (326 mg, 1.0 mmol, 5.0 eq.), aryl bromide (0.22 mmol, 1.1
eq.), and 0.4 mL of DI water were added to the reaction vial. A septum cap was secured tightly on
the vial and taped. The septum cap was punctured with a needle to purge the reaction mixture with
argon for 5-10 minutes with an outlet to a bubbler. The puncture was taped over to prevent any
evaporation of solvent. The reactions were stirred at reflux (85°C) for 24 hours. Upon reaction
completion, the crude mixture was allowed to cool to room temperature and added to a separatory
funnel that contained 1M HCl (10 mL). The organic layer was extracted with dichloromethane (15
mL x 3). The combined organic layers were collected in a 100 mL round-bottom flask and
concentrated under vacuum to give the crude product. Mesitylene (0.04 mmol, 20 mol%) was
added to the crude mixture as an internal standard and dissolved in CDCl3 to be analyzed by 1H
NMR. If cross-coupling product was present in a reasonable amount, the crude product was
isolated by crystallization techniques.
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Appendix I: X-Ray Crystallography

100

Figure 1. Perspective view of the molecular structure of the C19H29BO4 with the atom labeling
scheme for the non-hydrogen atoms. The thermal ellipsoids are scaled to enclose 50% probability.

101

Description of the X-ray Structural Analysis of C19H29BO4
A colorless crystal of C19H29BO4 was covered in a polybutene oil (Sigma-Aldrich) and placed on
the end of a MiTeGen loop. The sample was cooled to 100 K with an Oxford Cryostream 700
system and optically aligned on a Bruker AXS D8 Venture fixed-chi X-ray diffractometer
equipped with a Triumph monochromator, a Mo Kα radiation source ( = 0.71073 Å), and a
PHOTON 100 CMOS detector. Two sets of 12 frames each were collected using the omega scan
method with a 10 s exposure time. Integration of these frames followed by reflection indexing
and least-squares refinement produced a crystal orientation matrix for the monoclinic crystal
lattice that was used for the structural analysis.
Data collection consisted of the measurement of a total of 186 frames in one run using
omega scans with the detector held at 5.00 cm from the crystal. Frame scan parameters are
summarized in Table 1 below:

Table 1. Data collection details for C19H29BO4.

Run

2θ

ω

φ



Scan Width (º)

Frames

1

12.11

-170.89

-245.11

54.79

1.00

186

Exposure
Time (sec)
30.00

The APEX2 software program (version 2014.1-1)1 was used for diffractometer control,
preliminary frame scans, indexing, orientation matrix calculations, least-squares refinement of cell
parameters, and the data collection. The frames were integrated with the Bruker SAINT software
package using a narrow-frame algorithm. The integration of the data using a monoclinic unit cell
yielded a total of 9820 reflections to a maximum θ angle of 27.53° (0.77 Å resolution), of which
4463 were independent (average redundancy 2.200, completeness = 99.0%, Rint = 2.05%, Rsig =
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3.38%) and 3341 (74.86%) were greater than 2σ(F2). The final cell constants of a = 10.8565(7)
Å, b = 16.1793(11) Å, c = 12.2433(9) Å, β = 114.1484(19)°, volume = 1962.3(2) Å3, are based
upon the refinement of the XYZ-centroids of 5314 reflections above 20 σ(I) with 6.218° < 2θ <
54.98°. Data were corrected for absorption effects using the multi-scan method (SADABS). The
ratio of minimum to maximum apparent transmission was 0.850. The calculated minimum and
maximum transmission coefficients (based on crystal size) are 0.958 and 0.978.
The structure was solved by direct methods and difference Fourier analysis using the
programs provided by SHELXL-2014.2 Idealized positions for the hydrogen atoms were included
as fixed contributions using a riding model with isotropic temperature factors set at 1.2 (methine,
methylene, and aromatic hydrogens) or 1.5 (methyl hydrogens) times that of the adjacent carbon
atom.

The positions of the methyl hydrogen atoms were optimized by a rigid rotating group

refinement with idealized angles. The fractional coordinates and isotropic thermal parameter of
the hydrogen atom bound to oxygen atom O(3) were refined. Full-matrix least-squares refinement,
based upon the minimization of wi |Fo2 - Fc2|2, with weighting wi-1 = [2(Fo2) + (0.0796 P)2 +
1.4928 P], where P = (Max (Fo2, 0) + 2 Fc2)/3.2 The final anisotropic full-matrix least-squares
refinement on F2 with 228 variables converged at R1 = 5.99%, for the 3341 observed data and
wR2 = 16.99% for all data. The goodness-of-fit was 1.043.3
A correction for secondary extinction was not applied. The largest peak in the final difference
electron density synthesis was 0.479 e-/Å3 and the largest hole was -0.277 e-/Å3 with an RMS
deviation of 0.063 e-/Å3.

The linear absorption coefficient, atomic scattering factors, and

anomalous dispersion corrections were calculated from values found in the International Tables of
X-ray Crystallography.4

103

References
1. APEX2 is a Bruker AXS crystallographic software package for single crystal data collection,
reduction and preparation.
2. Sheldrick, G. M., SHELXL-2014, Crystallographic software package, Bruker AXS, Inc.,
Madison, Wisconsin, USA.
3. R1 = (||Fo| - |Fc||) / |Fo|, wR2 = [w(Fo2 - Fc2)2] / wFo22]]1/2, Rint. = Fo2 - Fo2(mean)|2/
Fo2], and GOF = [w(Fo2 - Fc2)2] / (n-p)]1/2, where n is the number of reflections and p is the
total number of parameters which were varied during the last refinement cycle.
4. International Tables for X-ray Crystallography (1974). Vol. IV, p. 55. Birmingham: Kynoch
Press. (Present distributor, D. Reidel, Dordrecht.).

104

Table 2. Crystal data for C19H29BO4.
Identification code
Empirical formula
Emp. formula weight
Temperature
Wavelength
Crystal size
Crystal system
Space group
Unit cell dimensions

Volume
Z
Density (calculated)
Absorption coefficient
F(000)

bp38cms
C19H29BO4
332.23 g/mol
100(2) K
0.71073 Å
0.296 x 0.376 x 0.572 mm
monoclinic
P 21/c (No. 14)
a = 10.8565(7) Å
α = 90°
b = 16.1793(11) Å
β = 114.1484(19)°
c = 12.2433(9) Å
γ = 90°
3
1962.3(2) Å
4
1.125 g/cm3
0.076 mm-1
720

Table 3. Data collection and structure refinement for C19H29BO4.
Theta range
3.11 to 27.53°
Index ranges
-14 ≤ h ≤ 14, -20 ≤ k ≤ 20, -10 ≤ l ≤ 15
Reflections
9820
Independent reflections
4463 [R(int) = 0.0205]
Coverage of independent
99.0%
reflections
Absorption correction
multi-scan
Max. and min. transmission 0.978 and 0.958
Refinement method
Full-matrix least-squares on F2
Refinement program
SHELXL-2014 (Sheldrick, 2014)
Data / restraints / parameters 4463 / 0 / 228
Goodness-of-fit on F2
1.043
Final R indices
3341 data; I>2σ(I) R1 = 0.0599, wR2 = 0.1513
all data
R1 = 0.0828, wR2 = 0.1699
- 3
Largest diff. peak and hole 0.479 and -0.277 e /Å
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Table 4. Atomic coordinates and equivalent isotropic atomic displacement parameters (Å2) for
C19H29BO4. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.

O1
O2
O3
O4
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
B1

x/a
0.18336(13)
0.40152(13)
0.99378(13)
0.15940(13)
0.23327(17)
0.21550(18)
0.24182(18)
0.28541(18)
0.30608(19)
0.28030(19)
0.3113(2)
0.4596(3)
0.2196(3)
0.2926(3)
0.20590(18)
0.11863(18)
0.33550(18)
0.18679(18)
0.34081(18)
0.1314(2)
0.0991(2)
0.3878(2)
0.3900(2)
0.3076(2)

y/b
0.09621(8)
0.13201(8)
0.93161(9)
0.00541(9)
0.83529(11)
0.78024(12)
0.69629(12)
0.66417(11)
0.72053(12)
0.80403(11)
0.57146(12)
0.55401(15)
0.52022(15)
0.54568(15)
0.92702(11)
0.95931(11)
0.97769(11)
0.18683(11)
0.20477(11)
0.21481(13)
0.21740(13)
0.20432(12)
0.28159(12)
0.07076(13)

z/c
0.34778(12)
0.38822(12)
0.11436(13)
0.09922(12)
0.27292(15)
0.35184(16)
0.34807(16)
0.26432(16)
0.18685(17)
0.19114(16)
0.2584(2)
0.3425(2)
0.2981(3)
0.1326(2)
0.27983(16)
0.15551(16)
0.33882(17)
0.35048(16)
0.41902(17)
0.22075(17)
0.41262(19)
0.55435(17)
0.37939(19)
0.35792(18)

U(eq)
0.0234(3)
0.0252(3)
0.0284(3)
0.0289(3)
0.0196(4)
0.0214(4)
0.0229(4)
0.0219(4)
0.0238(4)
0.0230(4)
0.0306(5)
0.0494(7)
0.0661(10)
0.0525(7)
0.0206(4)
0.0208(4)
0.0230(4)
0.0225(4)
0.0228(4)
0.0286(4)
0.0284(4)
0.0280(4)
0.0305(5)
0.0227(4)
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Table 5. Interatomic distances (Å) for C19H29BO4.
O1-B1
O2-B1
O3-C12
C1-C2
C1-C11
C3-C4
C4-C7
C7-C9
C7-C8
C11-C13
C14-C16
C14-C15
C15-C18

1.366(2)
1.360(2)
1.317(2)
1.384(3)
1.523(2)
1.394(3)
1.533(3)
1.519(3)
1.541(3)
1.530(2)
1.519(3)
1.561(3)
1.521(3)

O1-C14
O2-C15
O4-C12
C1-C6
C2-C3
C4-C5
C5-C6
C7-C10
C11-C12
C13-B1
C14-C17
C15-C19

1.467(2)
1.472(2)
1.215(2)
1.392(3)
1.393(3)
1.398(3)
1.385(3)
1.528(3)
1.519(2)
1.572(3)
1.524(3)
1.509(3)

Table 6. Bond angles (°) for C19H29BO4.
B1-O1-C14
C2-C1-C6
C6-C1-C11
C2-C3-C4
C3-C4-C7
C6-C5-C4
C9-C7-C10
C10-C7-C4
C10-C7-C8
C12-C11-C1
C1-C11-C13
O4-C12-C11
C11-C13-B1
O1-C14-C17
O1-C14-C15
C17-C14-C15
O2-C15-C18
O2-C15-C14
C18-C15-C14
O2-B1-C13

106.51(14)
117.71(17)
122.11(16)
121.61(17)
121.54(17)
121.29(18)
109.8(2)
111.30(17)
107.1(2)
109.60(14)
112.69(15)
123.83(16)
112.78(15)
108.69(15)
102.11(13)
114.94(15)
106.83(15)
101.94(13)
113.12(16)
124.71(17)

B1-O2-C15
C2-C1-C11
C1-C2-C3
C3-C4-C5
C5-C4-C7
C5-C6-C1
C9-C7-C4
C9-C7-C8
C4-C7-C8
C12-C11-C13
O4-C12-O3
O3-C12-C11
O1-C14-C16
C16-C14-C17
C16-C14-C15
O2-C15-C19
C19-C15-C18
C19-C15-C14
O2-B1-O1
O1-B1-C13

106.75(14)
120.15(16)
121.02(17)
116.93(17)
121.52(17)
121.40(17)
111.25(18)
109.2(2)
108.02(17)
111.39(15)
123.29(16)
112.88(16)
106.19(14)
111.36(16)
112.68(16)
108.80(15)
110.44(16)
114.98(15)
114.04(17)
121.23(17)
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Table 7. Anisotropic atomic displacement parameters (Å2) for C19H29BO4.
The
anisotropic atomic displacement factor exponent takes the form: -2π2[ h2 a*2 U11 +
... + 2 h k a* b* U12].

O1
O2
O3
O4
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
B1

U11
0.0206(6)
0.0215(7)
0.0204(7)
0.0212(7)
0.0167(8)
0.0196(8)
0.0225(9)
0.0191(8)
0.0253(9)
0.0263(9)
0.0373(11)
0.0547(16)
0.082(2)
0.080(2)
0.0212(9)
0.0216(9)
0.0194(9)
0.0218(9)
0.0208(9)
0.0258(10)
0.0221(9)
0.0259(10)
0.0301(10)
0.0200(10)

U22
0.0205(6)
0.0209(7)
0.0287(7)
0.0324(8)
0.0177(8)
0.0237(9)
0.0220(9)
0.0178(8)
0.0228(9)
0.0199(9)
0.0166(9)
0.0347(13)
0.0187(11)
0.0255(11)
0.0174(8)
0.0143(8)
0.0232(9)
0.0188(9)
0.0204(9)
0.0320(10)
0.0297(10)
0.0260(10)
0.0251(10)
0.0253(10)

U33
U23
U13
0.0247(7) -0.0031(5) 0.0050(5)
0.0300(7) -0.0045(5) 0.0073(6)
0.0280(7)
0.0067(6)
0.0017(6)
0.0261(7)
0.0064(6)
0.0024(5)
0.0177(8) -0.0008(6) 0.0003(6)
0.0184(8) -0.0011(7) 0.0053(7)
0.0213(9)
0.0060(7)
0.0062(7)
0.0245(9)
0.0020(7)
0.0046(7)
0.0233(9) -0.0002(7) 0.0101(8)
0.0201(9)
0.0041(7)
0.0067(7)
0.0393(12) 0.0026(8)
0.0170(9)
0.0543(16) 0.0040(11) 0.0179(13)
0.128(3)
0.0060(14)
0.074(2)
0.0439(14) -0.0071(10) 0.0173(13)
0.0193(8) -0.0014(7) 0.0045(7)
0.0218(9) -0.0035(7) 0.0041(7)
0.0217(9) -0.0018(7) 0.0038(7)
0.0228(9) -0.0018(7) 0.0049(7)
0.0242(9) -0.0031(7) 0.0060(7)
0.0231(9)
0.0033(8)
0.0050(8)
0.0301(10) -0.0009(8) 0.0075(8)
0.0238(10) -0.0039(8) 0.0017(8)
0.0362(11) 0.0006(8)
0.0134(9)
0.0177(9) -0.0026(8) 0.0026(8)

U12
0.0000(5)
0.0021(5)
-0.0017(5)
-0.0022(6)
0.0005(6)
-0.0004(7)
-0.0004(7)
0.0019(7)
0.0019(7)
0.0003(7)
0.0051(8)
0.0217(12)
-0.0010(12)
0.0053(12)
0.0023(7)
0.0015(7)
0.0014(7)
0.0026(7)
0.0032(7)
0.0073(8)
0.0045(8)
0.0011(8)
-0.0002(8)
0.0017(8)
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Table 8. Hydrogen atom coordinates and isotropic atomic displacement parameters (Å2) for
C19H29BO4.

H3O
H2
H3
H5
H6
H8A
H8B
H8C
H9A
H9B
H9C
H10A
H10B
H10C
H11
H13A
H13B
H16A
H16B
H16C
H17A
H17B
H17C
H18A
H18B
H18C
H19A
H19B
H19C

x/a
-0.057(3)
0.1849
0.2298
0.3384
0.2950
0.4755
0.5191
0.4783
0.1255
0.2438
0.2305
0.3078
0.3574
0.2005
0.1533
0.3868
0.3921
0.1919
0.1249
0.0416
0.0045
0.1089
0.1276
0.3523
0.3547
0.4867
0.4869
0.3414
0.3735

y/b
0.9568(17)
0.8000
0.6600
0.7012
0.8407
0.5701
0.5859
0.4949
0.5366
0.5295
0.4615
0.4861
0.5755
0.5590
0.9331
0.9751
0.9528
1.1964
1.2752
1.1909
1.2038
1.2774
1.1906
1.1552
1.2541
1.2034
1.2884
1.3298
1.2764

z/c
0.040(3)
0.4095
0.4039
0.1302
0.1371
0.4243
0.3160
0.3405
0.2520
0.3835
0.2843
0.1311
0.1102
0.0757
0.3300
0.2882
0.4173
0.1843
0.2173
0.1770
0.3635
0.4234
0.4909
0.5784
0.5793
0.5925
0.4276
0.3900
0.2948

U(eq)
0.051(8)
0.026
0.027
0.029
0.028
0.074
0.074
0.074
0.099
0.099
0.099
0.079
0.079
0.079
0.025
0.028
0.028
0.043
0.043
0.043
0.043
0.043
0.043
0.042
0.042
0.042
0.046
0.046
0.046
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Figure 1. Perspective view of the molecular structure of C19H29BO4 with the atom labeling scheme
for the non-hydrogen atoms. The thermal ellipsoids are scaled to enclose 50% probability.
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Description of the X-ray Structural Analysis of C19H29BO4·HOCMe2CMe2OH
A colorless crystal of C19H29BO4·HOCMe2CMe2OH was covered in a polybutene oil (SigmaAldrich) and placed on the end of a MiTeGen loop. The sample was cooled to 100 K with an
Oxford Cryostream 700 system and optically aligned on a Bruker AXS D8 Venture fixed-chi Xray diffractometer equipped with a Triumph monochromator, a Mo Kα radiation source ( =
0.71073 Å), and a PHOTON 100 CMOS detector. Three sets of 12 frames each were collected
using the omega scan method with a 10 s exposure time. Integration of these frames followed by
reflection indexing and least-squares refinement produced a crystal orientation matrix for the
triclinic crystal lattice that was used for the structural analysis.
Data collection consisted of the measurement of a total of 276 frames in three runs using
omega scans with the detector held at 5.00 cm from the crystal. Frame scan parameters are
summarized in Table 1 below:
Table 1. Data collection details for C19H29BO4·HOCMe2CMe2OH.

Run

2θ

ω

φ



Scan Width (º)

Frames

1
2
3

16.35
16.35
16.35

-165.34
-165.34
-165.34

0.00
-105.00
153.00

54.74
54.74
54.74

2.00
2.00
2.00

92
92
92

Exposure
Time (sec)
40.00
40.00
40.00

The APEX3 software program (version 2016.9-0)1 was used for diffractometer control,
preliminary frame scans, indexing, orientation matrix calculations, least-squares refinement of cell
parameters, and the data collection. The frames were integrated with the Bruker SAINT software
package using a narrow-frame algorithm. The integration of the data using a triclinic unit cell
yielded a total of 19008 reflections to a maximum θ angle of 27.50° (0.77 Å resolution), of which
6132 were independent (average redundancy 3.100, completeness = 99.6%, Rint = 3.40%, Rsig =
111

4.01%) and 4563 (74.41%) were greater than 2σ(F2). The final cell constants of a = 10.0852(5)
Å, b = 11.7620(6) Å, c = 12.1027(6) Å, α = 79.7176(13)°, β = 82.3089(13)°, γ = 72.4206(13)°,
volume = 1341.73(12) Å3, are based upon the refinement of the XYZ-centroids of 9961 reflections
above 20 σ(I) with 6.363° < 2θ < 60.11°. Data were corrected for absorption effects using the
multi-scan method (SADABS). The ratio of minimum to maximum apparent transmission was
0.881. The calculated minimum and maximum transmission coefficients (based on crystal size)
are 0.969 and 0.984.
The structure was solved by direct methods and difference Fourier analysis using the
programs provided by SHELXL-2014/7.2 The crystallographic asymmetric unit contains a
molecule of C19H29BO4 and a molecule of HOCMe2CMe2OH.

Idealized positions for the

hydrogen atoms bound to carbon atoms were included as fixed contributions using a riding model
with isotropic temperature factors set at 1.2 (methine, methylene, and aromatic hydrogens) or 1.5
(methyl hydrogens) times that of the adjacent carbon atom. The fractional coordinates of the two
hydroxyl hydrogens of HOCMe2CMe2OH were refined, whereas the position of the hydrogen of
the carboxylic group was idealized using a rigid rotating refinement of the O-H bond orientation.
The isotropic temperature factor for the hydrogen atoms bound to O were set at 1.5 times that of
the adjacent oxygen atom. Full-matrix least-squares refinement, based upon the minimization of 
wi |Fo2 - Fc2|2, with weighting wi-1 = [2(Fo2) + (0.0537 P)2 + 0.6234 P], where P = (Max (Fo2, 0)
+ 2 Fc2)/3.2 The final anisotropic full-matrix least-squares refinement on F2 with 306 variables
converged at R1 = 4.99%, for the 4563 observed data with I>2σ(I) and wR2 = 12.69% for all data.
The goodness-of-fit was 1.047.3
A correction for secondary extinction was not applied. The largest peak in the final difference
electron density synthesis was 0.604 e-/Å3 and the largest hole was -0.278 e-/Å3 with an RMS
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deviation of 0.050 e-/Å3.

The linear absorption coefficient, atomic scattering factors, and

anomalous dispersion corrections were calculated from values found in the International Tables of
X-ray Crystallography.4

References
1. APEX3 is a Bruker AXS crystallographic software package for single crystal data collection,
reduction and preparation.
2. Sheldrick, G. M., SHELXL-2014, Crystallographic software package, Bruker AXS, Inc.,
Madison, Wisconsin, USA.
3. R1 = (||Fo| - |Fc||) / |Fo|, wR2 = [w(Fo2 - Fc2)2] / wFo22]]1/2, Rint. = Fo2 - Fo2(mean)|2/
Fo2], and GOF = [w(Fo2 - Fc2)2] / (n-p)]1/2, where n is the number of reflections and p is the
total number of parameters which were varied during the last refinement cycle.
4. International Tables for X-ray Crystallography (1974). Vol. IV, p. 55. Birmingham: Kynoch
Press. (Present distributor, D. Reidel, Dordrecht.).
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Table 2. Crystal data for C19H29BO4·HOCMe2CMe2OH.
Identification code
Chemical formula
Formula weight
Temperature
Wavelength
Crystal size
Crystal system
Space group
Unit cell

Volume, Å3
Z
Density (calc)
Absorption
coefficient
F(000)

bp45cms
C25H43BO6
450.40 g/mol
100(2) K
0.71073 Å
0.204 x 0.293 x 0.418 mm
triclinic
P(-1) (No. 2)
a = 10.0852(5) Å
α = 79.7176(13)°
b = 11.7620(6) Å
β = 82.3089(13)°
c = 12.1027(6) Å
γ = 72.4206(13)°
1341.73(12)
2
1.115 g/cm3
0.077 mm-1
492

Table 3. Data collection and structure refinement for C19H29BO4·HOCMe2CMe2OH.
Theta range
3.18 to 27.50°
Index ranges
-13 ≤ h ≤ 13, -15 ≤ k ≤ 15, -15 ≤ l ≤ 15
Reflections
19008
Independent reflections 6132 [R(int) = 0.0340]
Coverage
99.6%
Absorption correction
multi-scan
Max. and min. trans.
0.984 and 0.969
Refinement method
Full-matrix least-squares on F2
Refinement program
SHELXL-2014/7 (Sheldrick, 2014)
Data / restraints /
6132 / 0 / 306
parameters
Goodness-of-fit on F2
1.047
4563
data;
Final R indices
R1 = 0.0499, wR2 = 0.1158
I>2σ(I)
all data
R1 = 0.0723, wR2 = 0.1269
Largest diff. peak and
0.604 and -0.278 e-/Å3
hole

114

Table 4. Atomic coordinates and equivalent isotropic atomic displacement parameters (Å2) for
C19H29BO4·HOCMe2CMe2OH. U(eq) is defined as one third of the trace of the orthogonalized
Uij tensor.

O1
O2
O3
O4
O5
O6
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
B1

x/a
0.10098(15)
0.06278(12)
0.45517(11)
0.40940(11)
0.07548(13)
0.95256(11)
0.24454(16)
0.16836(15)
0.10737(15)
0.05418(15)
0.06797(16)
0.96549(17)
0.84509(15)
0.83161(16)
0.93454(16)
0.73244(16)
0.65398(16)
0.5846(2)
0.5467(2)
0.55074(16)
0.54578(16)
0.48860(19)
0.69239(18)
0.5513(2)
0.65353(19)
0.23094(17)
0.10793(17)
0.14814(18)
0.97790(16)
0.0012(2)
0.84776(17)
0.37068(18)

y/b
0.90234(11)
0.72758(10)
0.74780(10)
0.94152(10)
0.94870(9)
0.82842(10)
0.81822(14)
0.73973(13)
0.79947(13)
0.71170(13)
0.59598(13)
0.57125(14)
0.66204(14)
0.77774(14)
0.80244(13)
0.63464(14)
0.55485(14)
0.61036(19)
0.52952(17)
0.79979(14)
0.91462(14)
0.82810(18)
0.70767(16)
0.02350(16)
0.89309(18)
0.77868(16)
0.81926(13)
0.77114(15)
0.78606(14)
0.65019(15)
0.84498(16)
0.83812(16)

z/c
0.27689(10)
0.26900(9)
0.32700(9)
0.36042(9)
0.88290(9)
0.07709(8)
0.46718(13)
0.42827(12)
0.31706(12)
0.51495(12)
0.57209(13)
0.65335(13)
0.67907(12)
0.62127(12)
0.54096(12)
0.76632(13)
0.73254(15)
0.62431(17)
0.82794(18)
0.24650(13)
0.29588(14)
0.13345(14)
0.24116(16)
0.20869(16)
0.37909(16)
0.97729(15)
0.90403(13)
0.79168(13)
0.96858(13)
0.99590(15)
0.90474(14)
0.38257(15)

U(eq)
0.0340(3)
0.0238(3)
0.0222(3)
0.0232(3)
0.0216(3)
0.0172(2)
0.0195(3)
0.0165(3)
0.0164(3)
0.0153(3)
0.0198(3)
0.0214(3)
0.0167(3)
0.0173(3)
0.0178(3)
0.0211(3)
0.0241(4)
0.0367(4)
0.0376(5)
0.0211(3)
0.0216(3)
0.0311(4)
0.0306(4)
0.0331(4)
0.0336(4)
0.0259(4)
0.0198(3)
0.0255(4)
0.0193(3)
0.0296(4)
0.0249(4)
0.0192(4)
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Table 5. Interatomic distances (Å) for C19H29BO4·HOCMe2CMe2OH.
O1-C3
O3-B1
O4-B1
O5-C21
C1-C2
C2-C3
C4-C5
C5-C6
C7-C8
C8-C9
C11-C12
C14-C17
C14-C15
C15-C18
C21-C22
C23-C24

1.2065(18)
1.365(2)
1.359(2)
1.4398(18)
1.531(2)
1.519(2)
1.388(2)
1.388(2)
1.390(2)
1.385(2)
1.515(3)
1.511(2)
1.557(2)
1.517(2)
1.524(2)
1.524(2)

O2-C3
O3-C14
O4-C15
O6-C23
C1-B1
C2-C4
C4-C9
C6-C7
C7-C10
C10-C11
C11-C13
C14-C16
C15-C19
C20-C21
C21-C23
C23-C25

1.3156(18)
1.4643(18)
1.4627(19)
1.4508(18)
1.571(2)
1.522(2)
1.391(2)
1.395(2)
1.513(2)
1.532(2)
1.526(2)
1.522(2)
1.515(2)
1.529(2)
1.552(2)
1.527(2)
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Table 6. Bond angles (°) for C19H29BO4·HOCMe2CMe2OH.
B1-O3-C14
C2-C1-B1
C3-C2-C1
O1-C3-O2
O2-C3-C2
C5-C4-C2
C4-C5-C6
C8-C7-C6
C6-C7-C10
C8-C9-C4
C12-C11-C13
C13-C11-C10
O3-C14-C16
O3-C14-C15
C16-C14-C15
O4-C15-C18
O4-C15-C14
C18-C15-C14
O5-C21-C20
O5-C21-C23
C20-C21-C23
O6-C23-C25
O6-C23-C21
C25-C23-C21
O4-B1-C1

107.13(12)
113.16(13)
110.28(12)
123.55(14)
113.16(12)
121.09(13)
121.01(14)
117.91(14)
120.79(14)
120.85(14)
110.61(15)
110.19(14)
105.93(12)
102.50(12)
113.18(14)
108.49(13)
102.79(12)
114.88(14)
104.74(13)
107.95(12)
111.23(13)
108.30(12)
108.65(12)
111.70(13)
124.81(14)

B1-O4-C15
C3-C2-C4
C4-C2-C1
O1-C3-C2
C5-C4-C9
C9-C4-C2
C5-C6-C7
C8-C7-C10
C9-C8-C7
C7-C10-C11
C12-C11-C10
O3-C14-C17
C17-C14-C16
C17-C14-C15
O4-C15-C19
C19-C15-C18
C19-C15-C14
O5-C21-C22
C22-C21-C20
C22-C21-C23
O6-C23-C24
C24-C23-C25
C24-C23-C21
O4-B1-O3
O3-B1-C1

107.12(12)
109.89(12)
113.03(12)
123.29(14)
118.22(13)
120.67(13)
120.82(14)
121.29(13)
121.18(14)
114.63(13)
111.96(14)
108.78(13)
110.73(14)
114.91(14)
106.50(13)
109.79(14)
113.71(14)
108.67(12)
111.51(14)
112.36(13)
105.16(12)
110.36(14)
112.36(13)
113.93(14)
121.22(14)
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Table 7.
Anisotropic atomic displacement parameters (Å2) for
C19H29BO4·HOCMe2CMe2OH. The anisotropic atomic displacement factor exponent
takes the form: -2π2[ h2 a*2 U11 + ... + 2 h k a* b* U12].

O1
O2
O3
O4
O5
O6
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
B1

U11
0.0580(9)
0.0360(7)
0.0195(6)
0.0184(6)
0.0345(7)
0.0260(6)
0.0183(8)
0.0155(7)
0.0151(7)
0.0153(7)
0.0192(8)
0.0248(8)
0.0172(7)
0.0160(7)
0.0199(8)
0.0213(8)
0.0183(8)
0.0292(10)
0.0275(10)
0.0190(8)
0.0156(7)
0.0284(9)
0.0225(9)
0.0297(10)
0.0263(9)
0.0196(8)
0.0249(8)
0.0316(9)
0.0238(8)
0.0392(10)
0.0200(8)
0.0156(8)

U22
0.0211(6)
0.0189(6)
0.0221(6)
0.0246(6)
0.0136(5)
0.0137(5)
0.0244(8)
0.0175(7)
0.0185(7)
0.0189(7)
0.0153(7)
0.0143(7)
0.0199(8)
0.0180(7)
0.0153(7)
0.0216(8)
0.0172(8)
0.0471(12)
0.0311(10)
0.0248(8)
0.0230(8)
0.0451(11)
0.0276(9)
0.0267(9)
0.0459(11)
0.0271(9)
0.0150(7)
0.0264(9)
0.0184(8)
0.0192(8)
0.0328(9)
0.0229(9)

U33
0.0286(7)
0.0184(6)
0.0251(6)
0.0274(6)
0.0168(5)
0.0123(5)
0.0171(7)
0.0146(7)
0.0148(7)
0.0122(7)
0.0213(8)
0.0223(8)
0.0141(7)
0.0167(7)
0.0173(7)
0.0181(7)
0.0345(9)
0.0385(11)
0.0490(12)
0.0198(8)
0.0248(8)
0.0234(9)
0.0380(10)
0.0410(11)
0.0338(10)
0.0306(9)
0.0187(7)
0.0195(8)
0.0168(7)
0.0322(9)
0.0236(8)
0.0196(8)

U23
0.0089(5)
0.0033(4)
-0.0028(5)
-0.0047(5)
0.0010(4)
-0.0016(4)
-0.0034(6)
0.0007(6)
0.0009(6)
-0.0009(6)
-0.0022(6)
0.0021(6)
-0.0033(6)
-0.0039(6)
0.0021(6)
-0.0023(6)
-0.0036(7)
-0.0073(9)
0.0042(9)
0.0003(6)
-0.0010(7)
-0.0076(8)
-0.0032(8)
0.0020(8)
-0.0067(9)
0.0007(7)
-0.0015(6)
-0.0079(7)
-0.0049(6)
-0.0069(7)
-0.0050(7)
-0.0024(7)

U13
-0.0203(6)
-0.0113(5)
0.0042(5)
0.0014(5)
-0.0052(5)
0.0003(4)
-0.0015(6)
-0.0009(6)
0.0003(6)
-0.0030(6)
0.0015(6)
0.0004(7)
-0.0016(6)
-0.0037(6)
-0.0057(6)
0.0030(6)
0.0036(7)
-0.0069(8)
0.0075(9)
0.0025(6)
-0.0007(6)
0.0000(7)
0.0060(8)
0.0009(8)
-0.0079(8)
-0.0080(7)
-0.0019(6)
0.0050(7)
-0.0007(6)
0.0081(8)
-0.0047(7)
-0.0066(7)

U12
-0.0197(6)
-0.0107(5)
-0.0091(5)
-0.0082(5)
-0.0073(5)
-0.0073(5)
-0.0075(6)
-0.0037(6)
-0.0059(6)
-0.0057(6)
-0.0012(6)
-0.0051(6)
-0.0065(6)
-0.0011(6)
-0.0047(6)
-0.0051(6)
-0.0041(6)
-0.0155(9)
-0.0109(8)
-0.0105(6)
-0.0052(6)
-0.0152(8)
-0.0063(7)
-0.0109(8)
-0.0152(8)
-0.0064(7)
-0.0051(6)
-0.0102(7)
-0.0069(6)
-0.0139(7)
-0.0087(7)
-0.0043(7)
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Table 8. Hydrogen atom coordinates and isotropic atomic displacement parameters (Å2)
C19H29BO4·HOCMe2CMe2OH.

H2
H5A
H6A
H1A
H1B
H2A
H5
H6
H8
H9
H10A
H10B
H11
H12A
H12B
H12C
H13A
H13B
H13C
H16A
H16B
H16C
H17A
H17B
H17C
H18A
H18B
H18C
H19A
H19B
H19C
H20A
H20B
H20C

x/a
0.0310
0.016(2)
-0.0566(19)
0.2793
0.1774
0.2386
0.1488
-0.0225
-0.2497
-0.0767
-0.3358
-0.2245
-0.2767
-0.4833
-0.4634
-0.3445
-0.5246
-0.4066
-0.4975
0.4802
0.5496
0.3961
0.7242
0.7592
0.6856
0.4717
0.6384
0.5475
0.6334
0.7467
0.6503
0.3106
0.2568
0.2042

y/b
0.7644
0.9742(18)
0.8991(18)
0.7797
0.8976
0.6615
0.5327
0.4915
0.8410
0.8824
0.7117
0.5944
0.4762
0.6882
0.5563
0.6225
0.6051
0.4939
0.4733
0.7539
0.8621
0.8865
0.6815
0.7437
0.6380
1.0454
1.0041
1.0914
0.9638
0.8794
0.8221
0.8026
0.6908
0.8166

z/c
0.2077
0.8391(18)
1.0671(16)
0.5415
0.4769
0.4154
0.5553
0.6919
0.6372
0.5031
0.7818
0.8372
0.7198
0.6345
0.6051
0.5633
0.8400
0.8972
0.8079
0.1127
0.0757
0.1391
0.3171
0.1922
0.2107
0.1630
0.1599
0.2468
0.4176
0.3388
0.4347
0.9352
0.9978
1.0459

for

U(eq)
0.036
0.032
0.026
0.023
0.023
0.02
0.024
0.026
0.021
0.021
0.025
0.025
0.029
0.055
0.055
0.055
0.056
0.056
0.056
0.047
0.047
0.047
0.046
0.046
0.046
0.05
0.05
0.05
0.05
0.05
0.05
0.039
0.039
0.039
119

H22A
H22B
H22C
H24A
H24B
H24C
H25A
H25B
H25C

0.0678
0.1769
0.2256
0.0841
0.0149
-0.0805
-0.2317
-0.1362
-0.1724

0.7999
0.6828
0.7997
0.6138
0.6159
0.6335
0.8210
0.8189
0.9329

0.7463
0.8052
0.7513
1.0379
0.9257
1.0417
0.9472
0.8303
0.8957

0.038
0.038
0.038
0.044
0.044
0.044
0.037
0.037
0.037
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Figure 1. Perspective view of the molecular structure of the C13H17O2F with the atom labeling
scheme for the non-hydrogen atoms. The thermal ellipsoids are scaled to enclose 50% probability.
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Description of the X-ray Structural Analysis of C13H17O2F
A colorless crystal of C13H17O2F was covered in a polybutene oil (Sigma-Aldrich) and placed on
the end of a MiTeGen loop. The sample was cooled to 100 K with an Oxford Cryostream 700
system and optically aligned on a Bruker AXS D8 Venture fixed-chi X-ray diffractometer
equipped with a Triumph monochromator, a Mo Kα radiation source ( = 0.71073 Å), and a
PHOTON 100 CMOS detector. Three sets of 12 frames each were collected using the omega scan
method with a 10 s exposure time. Integration of these frames followed by reflection indexing
and least-squares refinement produced a crystal orientation matrix for the monoclinic crystal
lattice that was used for the structural analysis.
Data collection consisted of the measurement of a total of 368 frames in three runs using
omega scans with the detector held at 5.00 cm from the crystal. Frame scan parameters are
summarized in Table 1 below:
Table 1. Data collection details for C13H17O2F.

Run

2θ

ω

φ



Scan Width (º)

Frames

1
2
3
4

21.65
21.65
21.65
21.65

-160.04
-160.04
-160.04
-160.04

-156.00
0.00
102.00
153.00

54.74
54.74
54.74
54.74

2.00
2.00
2.00
2.00

92
92
92
92

Exposure
Time (sec)
15.00
15.00
15.00
15.00

The APEX3 software program (version 2016.9-0)1 was used for diffractometer control,
preliminary frame scans, indexing, orientation matrix calculations, least-squares refinement of cell
parameters, and the data collection. The frames were integrated with the Bruker SAINT software
package using a narrow-frame algorithm. The integration of the data using a monoclinic unit cell
yielded a total of 17861 reflections to a maximum θ angle of 26.00° (0.81 Å resolution), of which
2345 were independent (average redundancy 7.617, completeness = 100.0%, Rint = 3.67%, Rsig =
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2.18%) and 2071 (88.32%) were greater than 2σ(F2). The final cell constants of a = 15.9977(12)
Å, b = 5.8881(3) Å, c = 14.1730(8) Å, β = 116.2710(15)°, volume = 1197.15(13) Å3, are based
upon the refinement of the XYZ-centroids of 9982 reflections above 20 σ(I) with 5.749° < 2θ <
64.73°. Data were corrected for absorption effects using the multi-scan method (SADABS). The
ratio of minimum to maximum apparent transmission was 0.876. The calculated minimum and
maximum transmission coefficients (based on crystal size) are 0.941 and 0.991.
The structure was solved by direct methods and difference Fourier analysis using the
programs provided by SHELXL-2014/7.2 Idealized positions for the hydrogen atoms were
included as fixed contributions using a riding model with isotropic temperature factors set at 1.2
(methine, methylene, and aromatic hydrogens) or 1.5 (methyl and hydroxylic hydrogens) times
that of the adjacent carbon atom. The t-butyl substituent is disordered. The disorder was refined
using a two-site model with the site occupancy ration of 60:40. The elongated thermal ellipsoid
for C(13) of the major site led to an A Alert when CheckCIF was run. The positions of the methyl
hydrogen atoms and the hydroxylic hydrogen bound to oxygen atom O(2) were optimized by a
rigid rotating group refinement with idealized angles. Full-matrix least-squares refinement, based
upon the minimization of wi |Fo2 - Fc2|2, with weighting wi-1 = [2(Fo2) + (0.0318 P)2 + 4.9862
P], where P = (Max (Fo2, 0) + 2 Fc2)/3.2 The final anisotropic full-matrix least-squares refinement
on F2 with 180 variables converged at R1 = 7.95%, for the 2071 observed data and wR2 = 20.36%
for all data. The goodness-of-fit was 1.206.3
A correction for secondary extinction was not applied. The largest peak in the final difference
electron density synthesis was 0.567 e-/Å3 and the largest hole was -0.328 e-/Å3 with an RMS
deviation of 0.082 e-/Å3.

The linear absorption coefficient, atomic scattering factors, and
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anomalous dispersion corrections were calculated from values found in the International Tables of
X-ray Crystallography.4

References
1. APEX3 is a Bruker AXS crystallographic software package for single crystal data collection,
reduction and preparation.
2. Sheldrick, G. M., SHELXL-2014, Crystallographic software package, Bruker AXS, Inc.,
Madison, Wisconsin, USA.
3. R1 = (||Fo| - |Fc||) / |Fo|, wR2 = [w(Fo2 - Fc2)2] / wFo22]]1/2, Rint. = Fo2 - Fo2(mean)|2/
Fo2], and GOF = [w(Fo2 - Fc2)2] / (n-p)]1/2, where n is the number of reflections and p is the
total number of parameters which were varied during the last refinement cycle.
4. International Tables for X-ray Crystallography (1974). Vol. IV, p. 55. Birmingham: Kynoch
Press. (Present distributor, D. Reidel, Dordrecht.).
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Table 2. Crystal data for C13H17O2F.
Identification code
Empirical formula
Emp. formula weight
Temperature
Wavelength
Crystal size
Crystal system
Space group
Unit cell dimensions

Volume
Z
Density (calculated)
Absorption coefficient
F(000)

bp42cms
C13H17FO2
224.26 g/mol
100(2) K
0.71073 Å
0.100 x 0.604 x 0.668 mm
monoclinic
P 21/c (No. 14)
a = 15.9977(12) Å α = 90°
b = 5.8881(3) Å
β = 116.2710(15)°
c = 14.1730(8) Å
γ = 90°
3
1197.15(13) Å
4
1.244 g/cm3
0.092 mm-1
480

Table 3. Data collection and structure refinement for C13H17O2F.
Theta range
2.84 to 26.00°
Index ranges
-19 ≤ h ≤ 19, -7 ≤ k ≤ 7, -17 ≤ l ≤ 17
Reflections
17861
Independent reflections
2345 [R(int) = 0.0367]
Coverage of independent
100.0%
reflections
Absorption correction
multi-scan
Max. and min. transmission 0.991 and 0.941
Refinement method
Full-matrix least-squares on F2
Refinement program
SHELXL-2014/7 (Sheldrick, 2014)
Data / restraints / parameters 2345 / 0 / 180
Goodness-of-fit on F2
1.206
Final R indices
2071 data; I>2σ(I) R1 = 0.0795, wR2 = 0.2000
all data
R1 = 0.0873, wR2 = 0.2036
- 3
Largest diff. peak and hole 0.567 and -0.328 e /Å
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Table 4. Atomic coordinates and equivalent isotropic atomic displacement parameters (Å2) for
C13H17O2F. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.

F1
O1
O2
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C11'
C12'
C13'

x/a
0.42100(16)
0.40342(17)
0.52793(17)
0.3351(2)
0.3519(2)
0.2873(2)
0.2035(2)
0.1879(3)
0.2533(3)
0.4052(2)
0.4470(2)
0.3585(3)
0.1330(3)
0.0342(5)
0.1334(10)
0.1506(12)
0.0444(8)
0.1777(9)
0.1130(11)

y/b
0.8555(4)
0.3514(5)
0.4187(5)
0.3655(6)
0.4364(6)
0.5696(6)
0.6354(6)
0.5659(6)
0.4322(7)
0.2115(6)
0.3346(6)
0.9926(6)
0.7806(7)
0.6789(18)
0.0134(17)
0.775(5)
0.828(3)
0.0154(18)
0.672(2)

z/c
0.0677(2)
0.9785(2)
0.13078(19)
0.1539(3)
0.2531(3)
0.2679(3)
0.1848(3)
0.0841(3)
0.0689(3)
0.1386(3)
0.0748(3)
0.0859(3)
0.2035(3)
0.1377(8)
0.1625(18)
0.3158(10)
0.1072(11)
0.2487(12)
0.2890(14)

U(eq)
0.0325(6)
0.0239(6)
0.0209(6)
0.0175(7)
0.0198(8)
0.0202(8)
0.0179(7)
0.0209(8)
0.0226(8)
0.0189(7)
0.0167(7)
0.0257(9)
0.0228(8)
0.043(3)
0.089(7)
0.139(11)
0.052(6)
0.030(3)
0.042(5)
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Table 5. Interatomic distances (Å) for C13H17O2F.
F1-C9
O2-C8
C1-C6
C2-C3
C4-C5
C5-C6
C7-C8
C10-C12
C10-C13'
C10-C12'

1.395(4)
1.281(4)
1.386(5)
1.384(5)
1.396(5)
1.401(5)
1.526(5)
1.490(13)
1.524(13)
1.558(12)

O1-C8
C1-C2
C1-C7
C3-C4
C4-C10
C7-C9
C10-C13
C10-C11'
C10-C11

1.231(4)
1.375(5)
1.530(5)
1.392(5)
1.528(5)
1.511(5)
1.490(14)
1.495(12)
1.556(9)

Table 6. Bond angles (°) for C13H17O2F.
C2-C1-C6
C6-C1-C7
C2-C3-C4
C3-C4-C10
C4-C5-C6
C9-C7-C8
C8-C7-C1
O1-C8-C7
F1-C9-C7
C11'-C10-C13'
C12-C10-C4
C13'-C10-C4
C12-C10-C11
C11'-C10-C12'
C4-C10-C12'

119.0(3)
120.9(3)
122.2(3)
121.1(3)
120.9(3)
111.3(3)
110.1(3)
120.9(3)
110.3(3)
110.8(9)
108.4(5)
109.6(6)
107.4(7)
106.7(9)
109.2(5)

C2-C1-C7
C1-C2-C3
C3-C4-C5
C5-C4-C10
C1-C6-C5
C9-C7-C1
O1-C8-O2
O2-C8-C7
C13-C10-C12
C13-C10-C4
C11'-C10-C4
C13-C10-C11
C4-C10-C11
C13'-C10-C12'

120.1(3)
120.4(3)
116.9(3)
121.9(3)
120.5(3)
110.1(3)
125.2(3)
113.8(3)
113.9(12)
111.6(7)
114.8(5)
107.0(10)
108.2(4)
105.2(8)

127

Table 7. Anisotropic atomic displacement parameters (Å2) for C13H17O2F.
The
anisotropic atomic displacement factor exponent takes the form: -2π2[ h2 a*2 U11 + ...
+ 2 h k a* b* U12].

F1
O1
O2
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C11'
C12'
C13'

U11
0.0311(12)
0.0242(13)
0.0192(13)
0.0170(17)
0.0180(17)
0.0210(18)
0.0193(17)
0.0201(17)
0.029(2)
0.0205(17)
0.0251(18)
0.030(2)
0.0202(18)
0.025(4)
0.072(9)
0.076(11)
0.022(6)
0.033(6)
0.060(11)

U22
0.0174(11)
0.0253(14)
0.0235(14)
0.0135(16)
0.0208(18)
0.0214(18)
0.0149(17)
0.0203(18)
0.026(2)
0.0170(17)
0.0097(16)
0.0155(18)
0.0229(19)
0.035(5)
0.026(5)
0.30(3)
0.071(13)
0.014(5)
0.027(6)

U33
0.0551(16)
0.0239(14)
0.0222(13)
0.0238(18)
0.0219(18)
0.0216(18)
0.0257(18)
0.0190(17)
0.0179(17)
0.0202(17)
0.0188(17)
0.043(2)
0.029(2)
0.074(6)
0.21(2)
0.036(6)
0.048(8)
0.063(8)
0.078(13)

U23
-0.0079(11)
-0.0068(11)
0.0029(11)
0.0035(14)
0.0065(15)
-0.0017(15)
-0.0028(14)
0.0013(15)
-0.0026(15)
0.0016(14)
0.0004(13)
-0.0031(17)
-0.0053(16)
-0.005(5)
-0.011(8)
-0.029(12)
-0.021(8)
-0.004(5)
0.022(7)

U13
0.0245(12)
0.0123(11)
0.0111(11)
0.0106(14)
0.0099(15)
0.0126(15)
0.0156(15)
0.0058(14)
0.0145(16)
0.0100(14)
0.0129(15)
0.0256(19)
0.0146(16)
0.025(4)
0.095(13)
0.021(7)
0.003(5)
0.038(6)
0.066(10)

U12
0.0017(10)
-0.0071(11)
-0.0014(11)
-0.0020(14)
0.0019(15)
-0.0036(15)
-0.0041(14)
0.0009(15)
-0.0026(16)
-0.0008(15)
0.0049(14)
-0.0017(16)
-0.0001(15)
0.003(4)
-0.002(5)
0.092(15)
0.029(7)
-0.001(5)
0.017(6)
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Table 8. Hydrogen atom coordinates and isotropic atomic displacement parameters (Å2) for
C13H17O2F.

H2
H2A
H3
H5
H6
H7
H9A
H9B
H11A
H11B
H11C
H12A
H12B
H12C
H13A
H13B
H13C
H11D
H11E
H11F
H12D
H12E
H12F
H13D
H13E
H13F

x/a
0.5507
0.4081
0.3007
0.1321
0.2416
0.4566
0.3361
0.3040
-0.0112
0.0343
0.0174
0.1881
0.0766
0.1358
0.2085
0.1562
0.0986
0.0584
0.0031
0.0137
0.2340
0.1330
0.1940
0.0839
0.0708
0.1715

y/b
0.4663
0.3937
0.6177
0.6099
0.3867
0.1745
-0.0891
0.0269
0.7607
0.5179
0.6941
1.0965
1.0938
1.0031
0.8562
0.6167
0.8476
0.9104
0.9193
0.6837
0.9929
1.1083
1.0928
0.5236
0.7704
0.6538

z/c
0.0913
0.3119
0.3371
0.0251
-0.0001
0.2093
0.1314
0.0183
0.1538
0.1553
0.0626
0.2127
0.1532
0.0947
0.3589
0.3395
0.3229
0.0559
0.1263
0.0763
0.3148
0.2617
0.1979
0.2651
0.3039
0.3531

U(eq)
0.031
0.024
0.024
0.025
0.027
0.023
0.031
0.031
0.065
0.065
0.065
0.134
0.134
0.134
0.209
0.209
0.209
0.078
0.078
0.078
0.046
0.046
0.046
0.063
0.063
0.063
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Figure 1. Perspective view of the molecular structure of C16H13F3O2 with the atom labeling scheme
provided for the non-hydrogen atoms. The thermal ellipsoids are scaled to enclose 50%
probability.
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Description of the X-ray Structural Analysis of C16H13F3O2
A colorless crystalline fragment of C16H13F3O2 was covered in polybutene oil (Sigma-Aldrich) and
placed on the end of a MiTeGen loop. The sample was cooled to 100 K with an Oxford Cryostream
700 system and optically aligned on a Bruker AXS D8 Venture fixed-chi X-ray diffractometer
equipped with a Triumph monochromator, a Mo Kα radiation source ( = 0.71073 Å), and a
PHOTON 100 CMOS detector. Three sets of 12 frames each were collected using the omega scan
method with a 10 second exposure time. Integration of these frames followed by reflection
indexing and least-squares refinement produced a crystal orientation matrix for the monoclinic
crystal lattice that was used for the structural analysis.
Data collection consisted of the measurement of a total of 246 frames in two runs using omega
scans with the detector held at 5.00 cm from the crystal. Frame scan parameters are summarized
in Table 1 below:
Table 1. Data collection details for C16H13F3O2.
Run

2θ

ω

φ



Scan Width (º)

Frames

1
2

22.76
22.76

-159.43
-159.43

167.28
51.97

54.78
54.78

1.50
1.50

123
123

Exposure
Time (sec)
15.00
15.00

The APEX3 software program (version 2016.9-0)1 was used for diffractometer control,
preliminary frame scans, indexing, orientation matrix calculations, least-squares refinement of cell
parameters, and the data collection. The frames were integrated with the Bruker SAINT software
package using a narrow-frame algorithm. The integration of the data using a monoclinic unit cell
yielded a total of 13411 reflections to a maximum θ angle of 30.00° (0.71 Å resolution), of which
3940 were independent (average redundancy 3.404, completeness = 99.8%, Rint = 2.82%, Rsig =
2.68%) and 3246 (82.39%) were greater than 2σ(F2). The final cell constants of a = 15.5902(7)
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Å, b = 5.5765(3) Å, c = 16.7923(8) Å, β = 111.6230(10)°, volume = 1357.17(12) Å3, are based
upon the refinement of the XYZ-centroids of 8082 reflections above 20 σ(I) with 6.780° < 2θ <
65.07°. Data were corrected for absorption effects using the multi-scan method (SADABS). The
calculated minimum and maximum transmission coefficients (based on the crystal dimensions)
are
0.945 and 0.955.
The structure was solved by the intrinsic phasing method and difference Fourier analysis using the
programs provided by SHELXL-2014/7.2

The crystallographic asymmetric unit contains a

molecule of C16H13F3O2. Idealized positions for the hydrogen atoms were included as fixed
contributions using a riding model with isotropic temperature factors set at 1.2 times that of the
adjacent carbon atom and 1.5 times that of the adjacent oxygen atom. Full-matrix least-squares
refinement, based upon the minimization of  wi |Fo2 - Fc2|2, with weighting wi-1 = [2(Fo2) +
(0.0490 P)2 + 0.5915 P], where P = (Max (Fo2, 0) + 2 Fc2)/3.2 The final full-matrix least-squares
refinement on F2 with 191 variables converged at R1 = 4.55% for the 3246 observed data with
I>2σ(I) and at wR2 = 12.21% for all data. The goodness-of-fit was 1.168.3
A correction for secondary extinction was not applied. The largest peak in the final difference
electron density synthesis was 0.426 e-/Å3 and the largest hole was -0.433 e-/Å3 and the RMS
deviation was 0.055 e-/Å3.

The linear absorption coefficient, atomic scattering factors, and

anomalous dispersion corrections were calculated from values found in the International Tables of
X-ray Crystallography.4
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Table 2. Crystal data for C16H13F3O2.
Ident. code
Emp. formula
Emp. form. wgt.
Temperature
Wavelength
Crystal size

bp58cms
C16H13F3O2
294.26 g/mol
100(2) K
0.71073 Å
0.386 x 0.392 x 0.472 mm

Crystal system

monoclinic

Space group
Unit cell

P21/c (No. 14)
a = 15.5902(7) Å
b = 5.5765(3) Å
c = 16.7923(8) Å
1357.17(12)
4
1.440 g/cm3
0.121 mm-1
608

Volume, Å3
Z
Density (calc)
Abs. coefficient
F(000)

α = 90°
β = 111.623(1)°
γ = 90°

Table 3. Data collection and structure refinement for C16H13F3O2.
Theta range
Index ranges
Reflections
Independent refls
Coverage
Abs. correction
Max. and min. trans.
Refinement method
Refinement program
Data / restrs / parms
GOF on F2
Final R indices

Largest diff. peak and hole

3.05 to 30.00°
-21 ≤ h ≤ 21, -7 ≤ k ≤ 7, -23 ≤ l ≤ 22
13411
3940 [R(int) = 0.0282]
99.8%
multi-scan
0.955 and 0.945
Full-matrix least-squares on F2
SHELXL-2014/7 (Sheldrick, 2014)
3940 / 0 / 191
1.168
3246
data; R1 = 0.0455, wR2 = 0.1140
I>2σ(I)
all data R1 = 0.0577, wR2 = 0.1221
0.426 and -0.433 e-/Å3
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Table 4. Atomic coordinates and equivalent isotropic atomic displacement parameters (Å2) for
C16H13F3O2. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.

F1
F2
F3
O1
O2
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16

x/a
0.59145(7)
0.61047(8)
0.48410(6)
0.91178(7)
0.92811(7)
0.83690(8)
0.88675(9)
0.91888(9)
0.90035(9)
0.85030(9)
0.81927(9)
0.80279(8)
0.88559(8)
0.72576(9)
0.68605(8)
0.63100(9)
0.59605(9)
0.61620(9)
0.67018(9)
0.70512(9)
0.57620(10)

y/b
0.85365(19)
0.4941(2)
0.5980(2)
0.34207(18)
0.73902(17)
0.5333(2)
0.3305(2)
0.3097(2)
0.4883(3)
0.6889(3)
0.7118(2)
0.5637(2)
0.5361(2)
0.3854(2)
0.4404(2)
0.6433(3)
0.7027(3)
0.5568(2)
0.3535(3)
0.2968(2)
0.6235(3)

z/c
0.11784(6)
0.08358(6)
0.09870(6)
0.49950(6)
0.51549(6)
0.63848(8)
0.67867(8)
0.76727(9)
0.81644(8)
0.77684(8)
0.68828(8)
0.54162(8)
0.51541(7)
0.49297(8)
0.39816(8)
0.36892(8)
0.28262(9)
0.22436(8)
0.25223(8)
0.33901(8)
0.13171(9)

U(eq)
0.0375(3)
0.0439(3)
0.0346(2)
0.0214(2)
0.0204(2)
0.0140(2)
0.0173(2)
0.0195(3)
0.0197(3)
0.0196(3)
0.0169(2)
0.0143(2)
0.0147(2)
0.0169(2)
0.0161(2)
0.0204(3)
0.0214(3)
0.0182(3)
0.0198(3)
0.0182(3)
0.0242(3)
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Table 5. Interatomic distances (Å) for C16H13F3O2.
F1-C16
F3-C16
O2-C8
C1-C2
C2-C3
C4-C5
C7-C8
C9-C10
C10-C11
C12-C13
C13-C16

1.3410(19)
1.3425(16)
1.3111(16)
1.3968(17)
1.3888(18)
1.3857(19)
1.5173(17)
1.5118(17)
1.3954(19)
1.3945(19)
1.4944(19)

F2-C16
O1-C8
C1-C6
C1-C7
C3-C4
C5-C6
C7-C9
C10-C15
C11-C12
C13-C14
C14-C15

1.3333(17)
1.2205(16)
1.3912(17)
1.5230(16)
1.3900(19)
1.3898(18)
1.5412(17)
1.3904(18)
1.3874(19)
1.386(2)
1.3911(19)
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Table 6. Bond angles (°) for C16H13F3O2.
C6-C1-C2
C2-C1-C7
C2-C3-C4
C4-C5-C6
C8-C7-C1
C1-C7-C9
O1-C8-C7
C10-C9-C7
C15-C10-C9
C12-C11-C10
C14-C13-C12
C12-C13-C16
C10-C15-C14
F2-C16-F3
F2-C16-C13
F3-C16-C13

119.13(11)
121.29(11)
120.31(12)
120.01(12)
107.39(10)
113.04(10)
122.85(11)
111.35(10)
121.54(12)
121.01(12)
120.40(12)
118.01(13)
120.89(12)
107.39(12)
112.93(13)
112.08(11)

C6-C1-C7
C3-C2-C1
C5-C4-C3
C5-C6-C1
C8-C7-C9
O1-C8-O2
O2-C8-C7
C15-C10-C11
C11-C10-C9
C11-C12-C13
C14-C13-C16
C13-C14-C15
F2-C16-F1
F1-C16-F3
F1-C16-C13

119.58(11)
120.13(12)
119.78(12)
120.63(12)
111.15(10)
123.75(11)
113.33(11)
118.75(12)
119.68(11)
119.34(13)
121.58(12)
119.60(12)
106.04(12)
105.12(13)
112.74(12)
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Table 7. Anisotropic atomic displacement parameters (Å2) for C16H13F3O2. The
anisotropic atomic displacement factor exponent takes the form: -2π2[ h2 a*2 U11 + ... + 2
h k a* b* U12].

F1
F2
F3
O1
O2
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16

U11
0.0430(6)
0.0475(6)
0.0189(4)
0.0212(5)
0.0214(5)
0.0119(5)
0.0180(6)
0.0191(6)
0.0202(6)
0.0214(6)
0.0167(6)
0.0141(5)
0.0147(5)
0.0153(5)
0.0130(5)
0.0186(6)
0.0179(6)
0.0139(5)
0.0201(6)
0.0177(6)
0.0200(6)

U22
0.0401(6)
0.0648(8)
0.0519(6)
0.0178(5)
0.0167(5)
0.0168(6)
0.0162(6)
0.0180(6)
0.0228(6)
0.0214(6)
0.0171(6)
0.0155(5)
0.0187(6)
0.0196(6)
0.0190(6)
0.0241(7)
0.0241(7)
0.0245(7)
0.0224(6)
0.0162(6)
0.0331(8)

U33
0.0244(5)
0.0179(4)
0.0249(5)
0.0304(5)
0.0281(5)
0.0145(5)
0.0192(6)
0.0203(6)
0.0154(6)
0.0182(6)
0.0181(6)
0.0146(5)
0.0104(5)
0.0163(6)
0.0171(6)
0.0187(6)
0.0209(6)
0.0156(6)
0.0188(6)
0.0215(6)
0.0180(6)

U23
0.0068(4)
-0.0072(5)
0.0041(4)
-0.0051(4)
-0.0004(4)
0.0012(4)
0.0002(5)
0.0044(5)
0.0022(5)
-0.0023(5)
0.0013(5)
0.0015(4)
0.0000(4)
0.0007(5)
-0.0018(4)
-0.0041(5)
-0.0011(5)
-0.0024(5)
-0.0066(5)
-0.0017(5)
-0.0025(5)

U13
0.0065(4)
0.0101(4)
-0.0016(3)
0.0158(4)
0.0150(4)
0.0062(4)
0.0087(5)
0.0058(5)
0.0058(5)
0.0097(5)
0.0079(5)
0.0068(4)
0.0043(4)
0.0062(4)
0.0064(4)
0.0070(5)
0.0056(5)
0.0047(4)
0.0093(5)
0.0082(5)
0.0054(5)

U12
-0.0138(5)
0.0142(6)
-0.0090(4)
-0.0038(4)
-0.0032(4)
-0.0016(4)
0.0008(5)
0.0016(5)
-0.0020(5)
-0.0001(5)
0.0019(5)
0.0003(4)
-0.0022(4)
-0.0029(5)
-0.0039(4)
0.0030(5)
0.0030(5)
-0.0048(5)
-0.0044(5)
-0.0017(5)
-0.0037(6)
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Table 8. Hydrogen atom coordinates and isotropic atomic displacement parameters (Å2) for
C16H13F3O2.

H2
H2A
H3
H4
H5
H6
H7
H9A
H9B
H11
H12
H14
H15

x/a
0.9775
0.8987
0.9537
0.9219
0.8372
0.7857
0.7781
0.7510
0.6761
0.6172
0.5588
0.6832
0.7425

y/b
0.7115
0.2066
0.1728
0.4728
0.8107
0.8507
0.7302
0.2204
0.3934
0.7422
0.8414
0.2535
0.1582

z/c
0.5078
0.6453
0.7944
0.8770
0.8102
0.6615
0.5271
0.5018
0.5163
0.4087
0.2634
0.2123
0.3581

U(eq)
0.031
0.021
0.023
0.024
0.024
0.02
0.017
0.02
0.02
0.025
0.026
0.024
0.022
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Appendix II: NMR Characterization
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Figure A2.1: 3-boronic acid pinacol ester-2-phenyl propionic acid (2a) – 1H NMR
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Figure A2.2: 3-boronic acid pinacol ester-2-phenyl propionic acid (2a) – 13C NMR
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Figure A2.3: 3-boronic acid pinacol ester-2-phenyl propionic acid (2a) – 11B NMR
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Figure A2.4: 3-boronic acid pinacol ester-2-(4-tertbuylphenyl) propionic acid (2b) – 1H NMR
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Figure A2.5: 3-boronic acid pinacol ester-2-(4-tertbuylphenyl) propionic acid (2b) – 13C NMR
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Figure A2.6: 3-boronic acid pinacol ester-2-(4-tertbuylphenyl) propionic acid (2b) – 11B NMR
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Figure A2.7: 3-boronic acid pinacol ester-2-(4-methylphenyl) propionic acid (2c) – 1H NMR
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Figure A2.8: 3-boronic acid pinacol ester-2-(4-methylphenyl) propionic acid (2c) – 13C NMR
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Figure A2.9: 3-boronic acid pinacol ester-2-(4-methylphenyl) propionic acid (2c) – 11B NMR
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Figure A2.10: 3-boronic acid pinacol ester-2-(4-isobutylphenyl) propionic acid (2d) – 1H NMR
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Figure A2.11: 3-boronic acid pinacol ester-2-(4-isobutylphenyl) propionic acid (2d) – 13C NMR
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Figure A2.12: 3-boronic acid pinacol ester-2-(4-isobutylphenyl) propionic acid (2d) – 11B NMR
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Figure A2.13: 3-boronic acid pinacol ester-2-(4-methoxyphenyl) propionic acid (2e) – 1H NMR
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Figure A2.14: 3-boronic acid pinacol ester-2-(4-methoxyphenyl) propionic acid (2e) – 13C NMR
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Figure A2.15: 3-boronic acid pinacol ester-2-(4-methoxyphenyl) propionic acid (2e) – 11B NMR
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Figure A2.16: 3-boronic acid pinacol ester-2-(4-N(methyl)acetamide phenyl) propionic acid (2f)
1
H NMR
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Figure A2.17: 3-boronic acid pinacol ester-2-(4-N(methyl)acetamide phenyl) propionic acid (2f)
13
C NMR
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Figure A2.18: 3-boronic acid pinacol ester-2-(4-N(methyl)acetamide phenyl) propionic acid (2f)
11
B NMR
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Figure A2.19: 3-boronic acid pinacol ester-2-(4-fluorophenyl) propionic acid (2g) – 1H NMR
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Figure A2.20: 3-boronic acid pinacol ester-2-(4-fluorophenyl) propionic acid (2g) – 13C NMR
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Figure A2.21: 3-boronic acid pinacol ester-2-(4-fluorophenyl) propionic acid (2g) – 11B NMR
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Figure A2.22: 3-boronic acid pinacol ester-2-(4-fluorophenyl) propionic acid (2g) – 19F NMR
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Figure A2.23: 3-boronic acid pinacol ester-2-(3-fluorophenyl) propionic acid (2h) – 1H NMR

163

Figure A2.24: 3-boronic acid pinacol ester-2-(3-fluorophenyl) propionic acid (2h) – 13C NMR
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Figure A2.25: 3-boronic acid pinacol ester-2-(3-fluorophenyl) propionic acid (2h) – 11B NMR
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Figure A2.26: 3-boronic acid pinacol ester-2-(3-fluorophenyl) propionic acid (2h) – 19F NMR
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Figure A2.27: 3-boronic acid pinacol ester-2-(2-fluorophenyl) propionic acid (2i) – 1H NMR
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Figure A2.28: 3-boronic acid pinacol ester-2-(2-fluorophenyl) propionic acid (2i) – 13C NMR
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Figure A2.29: 3-boronic acid pinacol ester-2-(2-fluorophenyl) propionic acid (2i) – 11B NMR
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Figure A2.30: 3-boronic acid pinacol ester-2-(2-fluorophenyl) propionic acid (2i) – 19F NMR
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Figure A2.31: 3-boronic acid pinacol ester-2-(6-methoxynaphthalene) propionic acid (2j)
1

H NMR
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Figure A2.32: 3-boronic acid pinacol ester-2-(6-methoxynaphthalene) propionic acid (2j)
13

C NMR
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Figure A2.33: 3-boronic acid pinacol ester-2-(6-methoxynaphthalene) propionic acid (2j)
11

B NMR
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Figure A2.34: 3-boronic acid pinacol ester-2-(3-phenoxyphenyl) propionic acid (2k) – 1H NMR
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Figure A2.35: 3-boronic acid pinacol ester-2-(3-phenoxyphenyl) propionic acid (2k) – 13C NMR
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Figure A2.36 3-boronic acid pinacol ester-2-(3-phenoxyphenyl) propionic acid (2k) – 11B NMR
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Figure A2.37 3-boronic acid pinacol ester-2-(3-fluorobiphenyl) propionic acid (2l) – 1H NMR
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Figure A2.38 3-boronic acid pinacol ester-2-(3-fluorobiphenyl) propionic acid (2l) – 13C NMR
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Figure A2.39 3-boronic acid pinacol ester-2-(3-fluorobiphenyl) propionic acid (2l) – 11B NMR
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Figure A2.40 3-boronic acid pinacol ester-2-(3-fluorobiphenyl) propionic acid (2l) – 19F NMR
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Figure A2.41 3-boronic acid pinacol ester-2-(4-trifluoromethylphenyl) propionic acid (2m)
1

H NMR
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Figure A2.42 3-boronic acid pinacol ester-2-(4-trifluoromethylphenyl) propionic acid (2m)
13

C NMR
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Figure A2.43 3-boronic acid pinacol ester-2-(4-trifluoromethylphenyl) propionic acid (2m)
11

B NMR
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Figure A2.44 3-boronic acid pinacol ester-2-(4-trifluoromethylphenyl) propionic acid (2m)
19

F NMR
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Figure A2.45 3-boronic acid pinacol ester-2-(4-cyanophenyl) propionic acid (2n) – 1H NMR
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Figure A2.46 3-boronic acid pinacol ester-2-(4-cyanophenyl) propionic acid (2n) – 13C NMR
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Figure A2.47 3-boronic acid pinacol ester-2-(4-cyanophenyl) propionic acid (2n) – 11B NMR
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Figure A2.48 3-boronic acid pinacol ester-2-(4-acetoxyphenyl) propionic acid (2o) – 1H NMR
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Figure A2.49 3-boronic acid pinacol ester-2-(4-acetoxyphenyl) propionic acid (2o) – 13C NMR
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Figure A2.50 3-boronic acid pinacol ester-2-(4-acetoxyphenyl) propionic acid (2o) – 11B NMR
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Figure A2.51 3-boronic acid pinacol ester-2-naphthyl propionic acid (2t) – 1H NMR
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Figure A2.52 3-boronic acid pinacol ester-2-naphthyl propionic acid (2t) – 13C NMR

192

Figure A2.53 3-boronic acid pinacol ester-2-naphthyl propionic acid (2t) – 11B NMR
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Figure A2.54 3-fluoro-2-phenyl propionic acid (5a) – 1H NMR
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Figure A2.55 3-fluoro-2-phenyl propionic acid (5a) – 13C NMR
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Figure A2.56 3-fluoro-2-phenyl propionic acid (5a) – 19F NMR
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Figure A2.57 3-fluoro-2-(4-tertbutylphenyl) propionic acid (5b) – 1H NMR
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Figure A2.58 3-fluoro-2-(4-tertbutylphenyl) propionic acid (5b) – 13C NMR
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Figure A2.59 3-fluoro-2-(4-tertbutylphenyl) propionic acid (5b) – 19F NMR
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Figure A2.60 3-fluoro-2-(4-methylphenyl) propionic acid (5c) – 1H NMR
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Figure A2.61 3-fluoro-2-(4-methylphenyl) propionic acid (5c) – 13C NMR
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Figure A2.62 3-fluoro-2-(4-methylphenyl) propionic acid (5c) – 19F NMR

202

Figure A2.63 3-fluoro-2-(4-isobutylphenyl) propionic acid (5d) – 1H NMR
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Figure A2.64 3-fluoro-2-(4-isobutylphenyl) propionic acid (5d) – 13C NMR
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Figure A2.65 3-fluoro-2-(4-isobutylphenyl) propionic acid (5d) – 19F NMR
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Figure A2.66 3-fluoro-2-(4-fluorophenyl) propionic acid (5g) – 1H NMR
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Figure A2.67 3-fluoro-2-(4-fluorophenyl) propionic acid (5g) – 13C NMR

207

Figure A2.68 3-fluoro-2-(4-fluorophenyl) propionic acid (5g) – 19F NMR

208

Figure A2.69 3-fluoro-2-(3-fluorobiphenyl) propionic acid (5l) – 1H NMR

209

Figure A2.70 3-fluoro-2-(3-fluorobiphenyl) propionic acid (5l) – 13C NMR

210

Figure A2.71 3-fluoro-2-(3-fluorobiphenyl) propionic acid (5l) – 19F NMR

211

Figure A2.72 3-fluoro-2-biphenyl propionic acid (5u) – 1H NMR

212

Figure A2.73 3-fluoro-2-biphenyl propionic acid (5u) – 13C NMR

213

Figure A2.74 3-fluoro-2-biphenyl propionic acid (5u) – 19F NMR
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